Page last updated: 2024-08-23

glucaric acid and ferric oxide, saccharated

glucaric acid has been researched along with ferric oxide, saccharated in 490 studies

Research

Studies (490)

TimeframeStudies, this research(%)All Research%
pre-199054 (11.02)18.7374
1990's38 (7.76)18.2507
2000's193 (39.39)29.6817
2010's202 (41.22)24.3611
2020's3 (0.61)2.80

Authors

AuthorsStudies
Glassman, E1
Ciuffi, M; Franchi-Micheli, S; Gentilini, G; Zilletti, L2
Balling, A; Hausmann, K; Kuse, R1
Casciani, CU; Di Nucci, G; Elia, L; Mandelli, F; Mariani, G; Meloni, C; Piazza, A; Taccone-Gallucci, M; Torromeo, C; Valeri, M1
Imamura, K1
Fridrich, R; Mueller, RM; Oberhaensli, RD1
Furukawa, K; Higashi, T; Kobayashi, M; Otsuka, H; Wakao, H1
Fujita, I; Hara, K; Hirota, M; Ito, N; Nagasawa, M; Nakatomi, M; Nasu, M; Saito, A; Shigeno, Y; Tanaka, H; Yamaguchi, K1
Fuchigami, T; Iida, M; Imamura, K; Okada, M; Omae, T1
Takishima, T; Tanno, Y1
Fuchigami, T; Fujita, K; Iida, M; Imamura, K; Murakami, M; Nanishi, F; Ogawa, K; Ohgushi, H; Okada, M; Omae, T; Yao, T1
Ito, T; Takemori, N1
Ageeva, TA; Shkurupiĭ, VA1
Wiśniewska-Knypl, JM; Wrońska-Nofer, T1
Fukaya, S; Imamura, T; Iwamoto, T; Kanou, H; Konjiki, O; Takasaki, M1
Irimajiri, S; Matsuoka, Y; Ohoike, H; Suzuki, A1
Fehr, J; Höchli, P; Wagenhäuser, FJ1
Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S1
Mercuriali, F2
Tryba, M1
Commerford, A; Haworth, C; Meyer, JH; Meyer, MP1
Danielson, BG; Derendorf, H; Geisser, P; Salmonson, T1
Blum, M; Iaina, A; Kaplan, E; Peer, G; Silverberg, DS1
Abbas, M; Abotalib, Z; al-Meshari, A; al-Momen, AK; al-Nuaim, L; Khashogji, T; Saddique, A1
Hörl, WH; Sunder-Plassmann, G2
Bowen, WH; Miguel, JC; Pearson, SK1
Hörl, WH; Spitzauer, S; Sunder-Plassmann, G1
Cynke, E1
Cazzola, M1
Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A1
Abdalla, AH; al-Hawas, F; al-Khader, AA; al-Sulaiman, MH; Mousa, DH; Popovich, W1
Bernière, J; Dehullu, JP; Gall, O; Murat, I1
Nonaka, D; Okamura, T; Takaki, K; Taketa, H; Tanaka, M; Umeno, M1
Andrade, S; Colaço, S; Oliveira, C; Ponce, P; Santos, JP; Silva, J; Ventura, H1
Sato, K; Shiraki, M1
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sundin, J; Tolmachev, V; Valind, S2
Atherton, DJ; Cox, I; Hann, I1
Eckstein, R; Glaser, A; Lauer, G; Rippel, R; Skoda, P; Weisbach, V; Zimmermann, R; Zingsem, J1
Dejaco, C; Fueger, GF; Gangl, A; Gasche, C; Lochs, H; Reinisch, W; Tillinger, W; Waldhoer, T1
Claris, O; Picaud, JC; Putet, G; Salle, BL1
Breymann, C; Huch, A; Huch, R; Hüttner, C; Krafft, A1
Asano, T; Baxter, JG; Maebashi, N; Yamaguchi, T1
Kho, B; Lim, PS; Wei, YH; Yu, YL1
Beshara, S; Lubberink, M; Lundqvist, H; Tolmachev, V1
Bailie, GR; Johnson, CA; Mason, NA1
Descombes, E; Fellay, G1
Adhikarla, R; Cavallo, G; Charytan, C; Gagnon, S; Levin, N; Spinowitz, BS; Van Wyck, DB1
Breymann, C; Huch, A; Huch, R; Krafft, A1
Grönhagen-Riska, C; Parkkinen, J; Peltonen, S; Rosenlöf, K; von Bonsdorff, L1
Chang, HY; Chen, KS; Kao, HH; Lee, CC; Tsai, CJ1
Hayde, M; Hayn, M; Herkner, K; Lombard, KA; Lubec, G; Pollak, A; Weninger, M; Widness, JA1
Al-Saloum, M; Charytan, C; Gagnon, S; Hafeez, T; Levin, N; Van Wyck, DB1
Kosch, M; Schaefer, RM2
Breymann, C; Huch, A; Huch, R; Visca, E1
Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T1
Inglis, H; Newstead, CG; Stoves, J1
Bahner, U; Bettger, H; Kosch, M; Matzkies, F; Schaefer, RM; Teschner, M1
Feichtenschlager, T; Gasche, C; Male, C; Mayer, A; Mittermaier, C; Petritsch, W; Waldhoer, T1
Chandler, G; Harchowal, J; Macdougall, IC1
Gottschalk, R; Kaltwasser, JP; Kessler, U; Möller, B; Stucki, G1
Duffy, CI1
Agullès, O; Bayoumeu, F; Laxenaire, MC; Vial, F; Zaccabri, A1
Hider, RC; Kooistra, MP; Marx, JJ; Rabelink, TJ; Rooyakkers, TM; Stroes, ES; van Faassen, EE1
Gosriwatana, I; Hider, RC; Kersting, S; Kooistra, MP; Lu, S; Marx, JJ; Nijhoff-Schutte, J1
Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A2
Canziani, ME; Draibe, SA; Manfredi, SR; Neto, MC; Rangel, EB; Yumiya, ST1
Baka, NE; Bayoumeu, F; Laxenaire, MC; Legagneur, H; Monnier-Barbarino, P; Subiran-Buisset, C1
Eran, A; Harmankaya, O1
Hanson, SY; Johnson, AC; Wasse, H; Zager, RA1
Breymann, C; Huch, A; Huch, R; Perewusnyk, G1
Froger, H; Gottrand, F; Guimber, D; Mention, K; Michaud, L; Neuville, S; Turck, D1
Chaimovitz, C; Mazor, D; Meyerstein, N; Tovbin, D; Vorobiov, M1
Oldham, FB1
Besarab, A; Yee, J1
Mushtaq, A; Wali, A1
Chuang, CL; Huang, TP; Liu, RS; Tarng, DC; Wei, YH1
Agarwal, R; Coyne, DW; Dahl, N; Folkert, VW; Michael, B; Myirski, P; Warnock, DG1
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sörensen, J; Tolmachev, V1
Fishbane, S1
Edwards, JH1
Calişkan, S; Camsari, T; Cavdar, C; Celik, A; Onvural, B; Sifil, A; Temiz, A; Yeniçerioğlu, Y1
Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR1
Blum, M; Iaina, A; Keren, G; Schwartz, D; Sheps, D; Silverberg, DS; Wexler, D1
Cohen, G; Deicher, R; Hörl, WH; Müllner, M; Ziai, F1
Acton, RT; Barton, JC; Coghlan, ME; Ozbirn, TW; Reymann, MT1
DESHMUKH, PL1
ASSALI, NS; NICHOLSON, DB2
NISSIM, JA2
DICKIE, W; HAGBERG, B; VAHLQUIST, B1
STILLE, G2
MEYER, F; STILLE, G1
PRIBILLA, W1
OVERKAMP, H3
HAGEN, A; LARSEN, V; LASSEN, N1
ARTETA, JL; PUCHOL, JR1
BENACERRAF, B; BIOZZI, G; HALPERN, BN; STIFFEL, C1
DEVOE, RW; MOSES, LE1
ELLIS, JT1
BUCHI, J; ZOPPI-HUG, R3
BENACERRAF, B; BIOZZI, G; STIFFEL, C1
FELLINGER, K; GISINGER, E; VETTER, H1
GAMERDINGER, G; PIETZONKA, H1
RICHTER, GW2
CIBIS, PA; YAMASHITA, T2
MOORE, RD; MUMAW, V; RUPP, J; SCHOENBERG, MD1
TRAUT, H1
GABBIANI, G; SELYE, H; VASKU, J1
MENZIES, DW; RYAN, GB1
MAGNANELLI, P; SALERA, U1
GARRISON, FE; HOBSON, JB; ITOGA, T; JONES, OW; LASZLO, J1
Bugat, R; Mourey, L; Séronie-Vivien, S; Tohfe, M1
Borisov, AV; Borisova, EV; Fesiuk, AF; Lovchinskiĭ, EV; Mordik, AI1
Avram, MM; Blaustein, DA; Chattopadhyay, J; Daoui, R; Gadh, R; Schwenk, MH; Singh, H1
Colfer, M1
Geisser, P1
Beshara, S; Danielson, BG1
Chernev, A; Chernev, T; Karag'ozova, Zh; Koleva, R1
Folkert, VW1
Breborowicz, A; Breborowicz, M; Polubinska, A; Tam, P; Wu, G1
Grabe, DW; Manley, HJ1
Anderson, J; Johnson, K; Van Wyck, D1
BENSLEY, EH; CAMERON, DG; GRAYSTON, V; WOOD, P1
BENSLEY, EH; CAMERON, DG; WOOD, P1
STRAHM, A; WALTER, F1
HOLLY, RG1
BERSIN, T1
BIERMAN, HR; BYRON, RL; KELLY, KH; WHITE, LP1
Al-Saloum, MM; Charytan, C; Schwenk, MH; Spinowitz, BS1
Blum, M; Iaina, A; Schwartz, D; Silverberg, D; Wexler, D1
Rodgers, GM; Silverstein, SB1
Goldenberg, H; Lutzky, B; Schaufler, R; Scheiber-Mojdehkar, B; Sturm, B1
Almer, S; Bodemar, G; Danielson, BG; Kechagias, S1
Hanson, SY; Johnson, AC; Zager, RA1
Derfler, K; Födinger, M; Hörl, WH; Jansen, M; Kletzmayr, J; Rainer, V; Sengoelge, G; Sunder-Plassmann, G1
Blumenstein, I; Dignass, AU; Jahnel, J; Schröder, O; Schrott, M; Stein, J1
Agarwal, R5
Aronoff, GR; Bennett, WM; Blumenthal, S; Charytan, C; Pennell, JP; Reed, J; Rothstein, M; Strom, J; Van Wyck, D; Wolfe, A; Yee, J1
Chester, K; McMahon, LP; Walker, RG1
Blaustein, DA; Schwenk, MH1
Eiam-Ong, S; Praditpornsilpa, K; Tiranathanagul, K; Tosukhowong, P; Tungsanga, K1
Cuenca Espiérrez, J; García Erce, JA; Martínez Martín, AA; Modrego Aranda, FJ; Solano, VM1
Cuenca, J; García-Erce, JA; Herrera, A; Izuel, M; Martínez, AA; Muñoz, M1
MEGASSINI, VE; MHANI, NO1
Abramowicz, P; Borawski, J; Gozdzikiewicz, J; Mysliwiec, M; Naumnik, B1
Bagdatoglu, O; Bali, M; Dhondt, AW; Guz, G; Kavutcu, M; Reis, KA; Sahinarslan, A; Sindel, S; Yalçin, R1
Abe, R; Horiuchi, T; Ogi, M; Wakabayashi, M; Wakabayashi, T1
Bozhinova, S; Ivanova, I; Lukanova, M1
El-Agroudy, A; El-Husseini, A; Hassan, N; Khalil, A; Sabry, A; Salem, A; Sheashaa, H; Sobh, M1
Cuenca, J; García-Erce, JA; Martínez, AA; Molina, J; Muñoz, M; Solano, VM1
Maslovsky, I1
Bailie, GR; Clark, JA; Lane, CE; Lane, PL1
Erturk, S; Keven, K; Kutlay, S; Nergizoglu, G1
Durandy, Y; Hulin, S1
Iida, M; Imamura, K; Okada, M; Okuda, S; Oochi, N; Sanai, T1
Dargan, PI; Jones, AL; Lawes, M; Thomson, AH; Wood, DM1
Macdougall, IC; Roche, A1
Zager, RA2
Berge, RK; Berstad, A; Erichsen, K; Hausken, T; Johansen, J; Nysaeter, G; Ostborg, J; Ulvik, RJ1
Collins, AJ; Obrador, GT; Roberts, TL; St Peter, WL1
Barut, Y; Eres, M; Gürsu, RU; Murat, B; Ozdemir, A; Selamet, U; Yalinbaş, B1
de Weerth, A; Dignass, AU; Herfarth, H; Junge, U; Mickisch, O; Reinshagen, M; Schreiber, S; Schröder, O; Schrott, M; Seidler, U; Stein, J1
Hörl, WH; Sengölge, G; Sunder-Plassmann, G1
Ahlmén, J; Chertow, GM; Mason, PD; Vaage-Nilsen, O1
Födinger, M; Hörl, WH; Mittermayer, F; Puttinger, H; Schaller, G; Scheiber-Mojdehkar, B; Sunder-Plassmann, G; Vychytil, A; Wolzt, M1
Martinez, CO; Mazey, RM; McMurray, S; Roppolo, M; Van Wyck, DB1
Laman, CA; Rodgers, GM; Silverstein, SB1
Govan, AD; Scott, JM1
Ghannam, M; Karkouti, K; McCluskey, SA; Quirt, I; Salpeter, MJ; Yau, TM1
Huang, X; Katz, SD; Zhang, Q; Zheng, H1
Anbu, AT; Bradbury, MG; Kemp, T; O'donnell, K; Smith, PA1
McLoughlin, P; Musthyala, R1
Karmiris, K; Kouroumalis, EA; Koutroubakis, IE; Makreas, S; Niniraki, M; Xidakis, C1
Cuenca, J; García-Erce, JA; Muñoz, M; Naveira, E; Palmer, JH; Seara, J1
Canser, E; Gilsanz, F; Gimeno, M; Gredilla, E; Martínez, B; Pérez Ferrer, A1
De Smet, R; Dhondt, AW; Glorieux, GL; Guz, G; Vanholder, RC; Waterloos, MA1
Barton Pai, A; Depczynski, J; McQuade, CR; Mercier, RC; Pai, MP1
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L1
Ambühl, PM; Binet, I; Dickenmann, M; Keusch, G; Lüthi, L; Schiesser, D; Schmidli, M; Tsinalis, D; Wüthrich, RP1
Alonzo, E; Bellorin-Font, E; Carlini, RG; Weisinger, JR1
Bartlett, FR; Bolger, AP; Chapman, CM; Kaprielian, R; O'Leary, J; Penston, HS; Pollock, N1
Cardona, R; Cuenca, J; García-Erce, JA; Martínez, F; Muñoz, M; Pérez-Serrano, L1
Bhandal, N; Russell, R1
Eiselt, J; Opatrný, K; Racek, J; Stehlík, P; Trefil, L1
Raja, R; Rizkala, AR; Sirken, G1
Breborowicz, A; Breborowicz, M; Górna, K; Oreopoulos, DG; Polubinska, A1
Gershanovich, ML; Livshits, ME; Makhnova, EV1
Juncà, J1
Cho, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, SW; Kim, YT; Nahm, EJ; Yoon, BS1
Cuenca Espiérrez, J; García-Erce, JA; Gómez Barrera, M; Izuel Rami, M; Rabanaque Hernández, MJ; Villar Fernández, I1
Breymann, C; Canclini, C; Geisser, P; Stahel, M; von Seefried, B1
Boyd, AV; Harford, A; McQuade, CR; Norenberg, JP; Pai, AB; Zager, PG1
Camps, J; Ferré, N; Joven, J; Mackness, B; Mackness, M; Marcas, L; Marsillach, J; Martínez-Vea, A1
Das, J; George, P; Itty, C; Pawar, B1
Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Rassi, S; Rohde, LE; Vilas-Boas, F1
Ranfaing, E1
Baribeault, D; Rosenberg, CL; Sane, R1
Deveci, M; Oymak, O; Sari, I; Sav, T; Sipahioglu, MH; Tokgoz, B; Utas, C1
Huch, R; Krafft, A; Schaefer, RM1
Breborowicz, A; Breborowicz, M; Oreopoulos, DG; Polubinska, A; Simon, M; Wanic-Kossowska, M1
Auerbach, M; Rodgers, GM1
Binder, T; Dvorská, M; Feldmár, P; Záhumenský, J; Zmrhalová, B1
Agarwal, R; Kaskas, MO; Minasian, R; Rizkala, AR; Trout, JR1
Vikrant, S1
Charytan, C; Reed, J; Yee, J1
Martinez, A; Thomas, J1
Cangiano, JL; Noble, S; Reed, J; Singh, H; Van Wyck, DB1
Agarwal, R; Bishu, K1
Breymann, C1
Grzegorzewska, AE1
Grekas, DM; Makedou, A; Makedou, K; Malindretos, P; Raptis, V; Rudenco, I; Sarafidis, PA1
Sato, K1
Di Gennaro, F; Duarte, P; Lombraña, A; Toblli, JE1
Francis, GS; Kanderian, A1
Geraci, G; Handelman, GJ; Kuhlmann, MK; Levin, NW; Wang, S1
Camsari, T; Cavdar, C; Cavdar, Z; Saglam, F; Uysal, S1
Enzmann, H; Langguth, P; Roth, S; Spicher, K1
NISSIM, JA; ROBSON, JM1
Pauly, RA; Wall, GC1
Boyd, A; Chan, LN; Norenberg, J; Pai, AB; Raj, D1
SLACK, HG; WILKINSON, JF1
Li, H; Wang, SX2
Jaber, BL1
Al Talib, K; Auerbach, M1
Allen, RP; Barker, PB; Beard, JL; Earley, CJ; Horská, A; Mohamed, MA1
Abraham, K; Ahmed, MS; Irvine, T; Lim, R; Wong, CF1
Auerbach, M; Goodnough, LT; Maniatis, A; Picard, D1
Birgegård, G; Hedenus, M1
Hung, SC; Kuo, KL; Tarng, DC; Wei, YH1
Cuenca, J; García-Erce, JA; Muñoz, M1
Auerbach, M; Ballard, H1
Kapelushnik, J; Levy, J; Moser, A; Pinsk, V; Yerushalmi, B1
Kaplinsky, C1
Anirban, G; Gupta, KL; Jha, V; Kohli, HS; Sakhuja, V1
Backe, B; Borthen, I; Kolås, T; Løkvik, B; Nakling, J; Rognerud Jensen, OH; Salvesen, KA; Smedvig, E; Westad, S; Økland, I1
Haraldsson, B; Nilsson, U; Stefánsson, BV2
Bailey, G; Cropper, L; Mostafa, S; Pugh-Clarke, K; Tagboto, S; Turner, J1
Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N1
Bolaños, L; González-Juanatey, C; Ranero, R; Testa, A1
Collins, AJ; Foley, RN; Gilbertson, DT; Ibrahim, HN; Zhang, R1
Abbadi, R; Haddad, A; Marji, A1
Lorch, JA; Pollak, VE; Satwah, S; Shukla, R1
Clark, SF1
Bisbe, E; Campos, A; Díez-Lobo, AI; García-Erce, JA; Muñoz, M; Sebastianes, C1
Breborowicz, A; Kupczyk, M; Oreopoulos, DG; Połubinska, A; Wanic-Kossowka, M1
Befrits, R; Blom, H; Eriksson, A; Grännö, C; Hjortswang, H; Lindgren, A; Lindgren, S; Ung, KA; Unge, P; Wikman, O1
Chung, HH; Kang, SB; Kim, SC; Kim, YH; Kim, YT1
Gorder, V; Khosla, S; Kuntz, S1
Bencaiova, G; von Mandach, U; Zimmermann, R1
Chiu, DY; Fenwick, S; Kalra, PA; Kolakkat, S; Lamerton, E; Peebles, G; Sinha, S1
Grote, L; Hedner, J; Leissner, L; Ulfberg, J1
Dejaco, C; Gasche, C; Kulnigg, S; Teischinger, L; Waldhör, T1
Asma, S; Boga, C; Ozdogu, H1
Cuenca, J; García-Erce, JA; Haman-Alcober, S; Herrera, A; Martínez, AA; Muñoz, M1
Nguyen, TV1
Bencaiova, G; Breymann, C; Krafft, A1
Angerosa, M; Cao, G; Oliveri, L; Toblli, JE4
Fujita, T; Fukumoto, S; Ito, N; Okamoto, T; Shimizu, Y; Sugimoto, T; Suzuki, H; Tada, Y; Yamauchi, M1
Durran, A; Edwards, TJ; Hosie, KB; Mellor, N; Noble, EJ1
García-Erce, JA; Gómez-Ramírez, S; Muñoz, M1
Dorrington, KL; León-Velarde, F; Nickol, AH; Privat, C; Ratcliffe, PJ; Rivera-Ch, M; Robbins, PA; Smith, TG; Talbot, NP1
Bruguera, J; Cladellas, M; Comín-Colet, J; Rizzo, M; Ruiz, S; Torres, A1
Cooper, B; Healy, H; Irish, AB; Kark, A; Kent, AB; Kerr, PG; McMahon, LP; Roger, SD1
Bârsan, L; Mircescu, G; Stanciu, A; Stancu, S1
Dangsuwan, P; Manchana, T1
Akatsuka, S; Hu, Q; Nagai, H; Ohara, H; Okazaki, Y; Takahashi, T; Toyokuni, S; Yamashita, Y1
Acheson, AG; Brookes, MJ; Iqbal, T; Simpson, JA; Tselepis, C1
Pramesh, CS; Ranganathan, P1
Alonso, E; Canser, E; Gilsanz, F; Gredilla, E; Martínez Serrano, B; Pérez-Ferrer, A1
Yee, J1
Chen, HH; Chen, YC; Chuang, CK; Lee, KF; Lin, HC; Wu, CJ1
Andreoli, MC; Carneiro, FD; Espósito, BP; Guimarães-Souza, NK; Mallet, AC; Matos, AC; Rangel, EB; Santos, BF1
Tampi, R1
Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Szczech, LA; Wolf, M1
Coma-Canella, I; Echeverria, A; Garcia-Fernandez, N; Páramo, JA; Sanchez-Ibarrola, A1
Berman, L; Firoz, BF; Goldberg, LH; Kaye, V; Landau, J1
Becker, K; Johnson, AC; Zager, RA1
Fernández-Gallego, J; Martín, MA; Sujan, S; Vega, E1
Agarwal, SK; Dogra, M; Gupta, A; Khaira, A1
Bhandari, S; Chinnappa, S1
Birgegård, G; Schneider, K; Ulfberg, J1
Hojs, N; Malovrh, M; Premru, V1
Benítez, PC; Cabello, LM; Chofles, LC; Lázaro, PS; Serrano-Trenas, JA; Ugalde, PF1
Goldenberg, H; Scheiber-Mojdehkar, B; Steinkellner, H; Sturm, B; Ternes, N1
Gupta, A; Olp, J; Pai, A; Reddy, S; Zha, J; Zhuo, J1
Dakshina Murty, KV; Naidu, MU; Neela, P; Ram, R; Swarnalatha, G1
Froessler, B; Papendorf, D1
Agarwal, R; Dahl, NV; Leehey, DJ; Olsen, SM1
Brin, JF; Crommelin, DJ; Klinger, E; Mühlebach, S; Schellekens, H; Storm, G1
Bager, P; Dahlerup, JF1
Breymann, C; Krafft, A1
Kim, S; Lee, SC; Lim, H; Yoon, J1
Conner, T; Hicks, P; McQuade, CR; Olp, J; Pai, AB1
Fenwick, S; Peebles, G1
Auerbach, M1
Buchanan, GR; Crary, SE; Hall, K1
Cheng, S; Coppol, E; Kaakeh, Y; Shelly, J; Shepler, B1
Dansaert, A; Kadri, A; Lafuma, A; Leonard, E; Rottembourg, J1
Atalay, H; Guney, I; Kaya, E; Solak, Y; Turk, S; Turkmen, K1
Elford, P; Khov-Tran, VV; Leoni, AL; Meier, T; Pater, C; Schropp, P1
Fujii, H; Fujimori, A; Fukagawa, M; Goto, S; Hasegawa, H; Komaba, H; Nishi, S; Nishioka, M; Takeda, Y; Umezu, M1
Acar, K; Atalay, H; Govec, N; Solak, Y; Turk, S1
Bach, V; Gay-Quéheillard, J; Khorsi-Cauet, H; Villegier, AS; Vu'o'ng Lê, B1
Bokemeyer, B; Chopey, IV; Evstatiev, R; Gasche, C; Gutzwiller, FS; Iqbal, T; Khalif, IL; Marteau, P; Riopel, L; Stein, J1
Battegay, E; Breymann, C; Furrer, J; Krayenbuehl, PA; Schulthess, G1
Bailie, GR; Hörl, WH; Verhoef, JJ1
Gisbert, JP; Gomollón, F1
Bisbe, E; Díez-Lobo, AI; García-Erce, JA; Muñoz, M1
Burrows, DM; Corcoran, HF; Dotzauer, H; Goggin, MM; Gozum, SD; Janis, GC; Lundberg, RA; Nguyen, A; Tann, CM1
Dorrington, KL; León-Velarde, F; Nickol, AH; Privat, C; Rivera-Ch, M; Robbins, PA; Smith, TG; Talbot, NP1
Degirmenci, NA; Musmul, A; Ozenc, F; Ozkurt, S; Sahin, G; Temiz, G; Yalcin, AU1
Bach, V; Gay-Quéheillard, J; Khorsi-Cauet, H; Lê, BV1
Fujita, T; Fukumoto, S; Kinoshita, Y; Taguchi, M; Wada, Y1
Chow, KU; Dignass, A; Stein, J1
Ganji, SH; Kamanna, VS; Norris, K; Shelkovnikov, S; Vaziri, ND1
Cordero, J; Muñoz, M; Naveira, E; Seara, J1
Korejo, R; Nasir, A; Yasmin, H1
Conner, TA; McQuade, C; Olp, J; Pai, AB1
Gollapudi, S; Hassanzadeh, T; Ichii, H; Masuda, Y; Saffarian, M; Vaziri, ND1
Christoph, P; Pfenniger, A; Schuller, C; Surbek, D1
Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J1
Bhandari, S; Muñoz, M; Reinisch, W; Staun, M1
Ghosh, P; Kaundal, A; Kochhar, PK1
Bradbury, BD; Brookhart, MA; Freburger, JK; Kshirsagar, AV; Ng, LJ1
Ávalos-Pinto, R; de la Llana-Ducrós, R; Garrido-Martín, P; Jimenez-Sosa, A; Martínez-Sanz, R; Nassar-Mansur, MI; Rodríguez Fortunez, PM; Virgos-Aller, TM1
Christoph, P; De Tejada, BM; Irion, O; Schuller, C; Studer, H; Surbek, D1
Borchard, G; Flühmann, B; Mühlebach, S1
Chen, J; Chen, X; Cheng, M; Peng, Y; Yang, L; Yin, L1
Abel, GA; Hevelone, N; Mandell, E; Okam, MM; Ross, A; Wentz, R1
Fukumoto, S; Mori, H; Okada, Y; Tanaka, Y; Yamamoto, S1
Hutchings, A; Jeans, A; Macdougall, IC; Wilson, PD1
Benmaadi, A; Bounhiol, C; Cohen, Y; Couprie, R; Dahan, H; Drahi, G; Griuncelli, M; Janklewicz, P; Loridon, C; Machado, G; Rostoker, G; Roy, M1
Cocchiaro, C; Dekker, G; Froessler, B; Hodyl, N; Saadat-Gilani, K1
Bockeria, LA; Bockeria, O; Donakanian, S; Sokolskaya, M1
Devasenapathy, N; Neogi, SB; Zodpey, S1
Goldstein, SL; Morris, D; Warady, BA1
Albareda Albareda, J; Blanco Rubio, N; Burillo Fuertes, P; Llorens Eizaguerri, M; Ranera García, M; Seral García, B1
Choi, GY; Kim, JS; Lee, ES; Lee, IS; Lee, JJ; Park, BR1
Akarsu, S; Demir, H; Oguzoncul, F; Selek, S1
Kildahl-Andersen, O; Kildahl-Andersen, R; Moore, KL; Tjønnfjord, GE1
Araki, T; Miyazaki, A; Nakamura, T; Ohshima, S; Shibamiya, T; Takaai, M; Yamamoto, K1
Amorós-Amorós, F; Enríquez-Ascarza, R; González-Martinez, C; Millán-del Valle, I; Redondo-Pachón, MD; Sirvent-Pedreño, AE1
Basora, M; Ciercoles, E; Colomina, MJ; Mora, L; Salazar, F; Tio, M1
Burden, R; Horgan, G; Moore, B; Pedlar, CR; Pollock, N; Whyte, GP1
Arao, T; Kurozumi, A; Mori, H; Okada, Y; Tanaka, Y; Torimoto, K; Yamamoto, S1
Lynn, S; McDaniel, J1
Biggar, P; Hahn, KM1
Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Piardi, D; Rassi, S; Rohde, LE; Soder, S; Vilas-Boas, F1
Bailie, GR; Leggett, RE; Levin, R; Li, H; Li, HD; Patadia, H; Schuler, C1
Barot, BS; Mehta, DM; Parejiya, PB; Shah, GB; Shelat, PK1
Amet, S; Deray, G; Janus, N; Launay-Vacher, V; Mahi, L; Rey, JB; Rouillon, L; Scotte, F; Zakin, L1
Münch, HG; Potthoff, SA1
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Seidel, L; Servais, S; Vanstraelen, G; Willems, E1
Barnuevo, MD; Contreras, C; Espadaler, J; Guillén, I; Lázaro, E; López-Román, J; Luque, A; Villegas, JA1
Bentley, DP; Meek, EM1
Achermann, R; Giger, M1
Bregman, DB; Buerkert, J; Butcher, A; Goodnough, LT; Hamerski, D; Harrington, RA; Iftikhar, H; Koch, TA; Mangoo-Karim, R; Martin, ER; Martinez, CO; Morris, D; Newman, GE; Onken, JE; Qunibi, WY; Ross, DL; Singh, B; Smith, MT1
Grim, K; Kotagal, S; Lee, B; Sung, AY1
Oertel, WH; Ries, V; Vadasz, D1
Forward, DP; Moppett, IK; Rowlands, M; Sahota, O1
Abbasi, S; Abdel-Razeq, H; Abdelelah, H; Jaber, R; Saadi, I1
Kalaivani, K1
Agarwal, N; Bhatla, N; Dash, BB; Kriplani, A; Kulshreshta, V; Mahey, R1
Michigami, T1
Braunhofer, P; Brock, E; Schneider, H; Troxler, J1
Akin, M; Atay, E; Erdogan, F; Karadeniz, C; Karakus, YT; Oztekin, O; Yilmaz, B1
Athibovonsuk, P; Manchana, T; Sirisabya, N1
Cornelius, C; Goldenberg, H; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B1
Toyokuni, S1
Hosoki, T; Ikuta, K; Kanada, H; Kohgo, Y; Moriguchi, Y; Sasaki, K; Sasaki, Y; Shimonaka, Y; Torimoto, Y1
Colah, R; Ghosh, K; Italia, K1
Coloma, JL; Esteve, J; Masoller, N; Palacio, M; Perelló, MF1
Faustino, PJ; Khan, MA; Raw, A; Shah, RB; Yang, Y; Yu, LX1
Dellanna, F; Hertel, J; Li, Z; Macdougall, IC; McLaughlin, J; Strauss, WE1
Boland, JP; Kusminsky, RE; Maxwell, D; Richmond, BK; Schlarb, CA; Todd Kuenstner, J; Willis Trammell, S; Witsberger, T1
Hammami Ghorbel, H; Lacour, JP; Passeron, T1
Mekic, M; Musanovic, A; Trnacevic, S1
Allen, LF; Bernard, K; Hetzel, D; Li, Z; Strauss, W; Urboniene, A1
Hung, SC; Kuo, KL; Lee, TS; Tarng, DC1
Cava-Sumner, B; Domínguez-Ortega, J; Kindelan-Recarte, C; Montojo-Guillén, C; Nuñez-Acevedo, B; Rodríguez-Jiménez, B1
Florey, L1
Berry, S; Burlew, CC; Cappa, A; Holena, DN; Jaouen, B; Jurkovich, J; Maier, R; Moore, EE; Pieracci, FM; Rodil, M; Stovall, RT1
Baranto, A; Barreto Henriksson, H; Brantsing, C; Junevik, K; Papadimitriou, N; Thorfve, A1
Angerosa, M; Cao, G; Dominici, FP; Giani, JF; Toblli, JE1
Artz, AS; Barnhart, H; Berger, NA; Chelune, G; Cohen, HJ; Ershler, WB; Gordeuk, VR; Prchal, J; Price, E; Rao, SV; Reuben, D; Roy, CN; Sapp, S; Schrier, SL; Supiano, MA; Walston, JD1
Li, J; Mi, C; Shi, Q; Xing, A; Yang, J; Yao, Q1
Corwin, HL; Napolitano, LM1
Beguin, Y; Jaspers, A1
Albinarrate, A; Barrachina, B; López-Ariznabarreta, C; López-Picado, A; Molano, J; Oiartzabal, I1
Cornelius, C; Goldenberg, H; Haider, K; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B1
Angerosa, M; Cao, G; Toblli, JE1
Di Gennaro, F; Rivas, C; Toblli, JE1
Chatzimichael, A; Mantadakis, E; Tsouvala, E; Xanthopoulou, V1
Afzal, R; Hanif, MO1
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É1
Leng, W; Li, J; Mi, C; Shi, Q; Wazir, R; Xing, A; Yang, J; Yao, Q1
Abdollahi, M; Baeeri, M; Baghaei, A; Golaghaei, A; Hasani, S; Hosseini, R; Navaei, M; Ostad, SN; Solgi, R1
Ambühl, PM; Bhandari, S; Christensen, JH; Coyne, DW; Essaian, AM; Kalra, PA; Kothari, J; Macdougall, IC; Thomsen, LL1
Connor, JR; Nixon, AM; Perno, JR; Webb, B; Zhang, X1
Ang, D; Bavry, AA; Beck, A; Efron, P; Rebel, A1
Agarwal, R; Kusek, JW; Pappas, MK1
Bouet, PE; Descamps, P; Gillard, P; Legendre, G; Ruiz, V; Sentilhes, L1
Fukumoto, S; Takashi, Y1
Allen, VM; Nash, CM1
Chen, L; Hong, H; Li, T; Man, C; Ren, X; Wang, H; Ye, P; Zhang, Q1
Fujii, M; Harada, D; Hashida, S; Hotta, K; Isozaki, H; Kato, Y; Kiura, K; Kubo, T; Kudo, K; Minami, D; Ochi, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanaka, T; Tanimoto, M; Toyooka, S1
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC1
Brookhart, MA; Ellis, AR; Freburger, JK; Kshirsagar, AV; Wang, L; Winkelmayer, WC1
Han, ZT; Hong, M; Li, H; Zhao, YS1
Graham, DJ; Houstoun, M; Kane, RC; Kelman, JA; Levenson, M; Limb, S; MaCurdy, TE; Mott, K; Reichman, ME; Ryan, Q; Sheu, TC; Wang, C; Wernecke, M; Wong, S; Worrall, C; Xie, D1
Couffignal, C; Driss, F; Dufour, G; Duval, X; Lasocki, S; Lefebvre, T; Piednoir, P; Puy, H; Rineau, E; Schilte, C1
Angmo, S; Mukhija, K; Sandhir, R; Singhal, K; Singhal, NK; Yadav, H; Yadav, K1
Chakraborty, S; Chaudhuri, MG; Dey, R; Jha, J1
Clavel, T; Fedorak, R; Haller, D; Lagkouvardos, I; Lee, T; Lucio, M; Michalke, B; Schmidt, A; Schmitt-Kopplin, P; Smirnov, K; Walker, A1
Bhatla, N; Kachhawa, G; Kriplani, A; Mahey, R; Mogili, KD; Saxena, R1
Amato, C; Barbieri, C; Bellocchio, F; Bolzoni, E; Canaud, B; Cattinelli, I; Gatti, E; Macdougall, IC; Mari, F; Martin, JD; Stopper, A; Stuard, S1
Crumbliss, AL; Gupta, A; Pratt, RD1
Absar, M; Chen, L; Choi, S; Petrochenko, P; Wong, SY; Wu, Y; Zheng, J1
Han, YM; Im, JP; Jung, HC; Kim, BG; Kim, JS; Koh, SJ; Shin, CM; Yoon, H1
Cao, G; Dominici, FP; Giani, JF; Rivas, C; Toblli, JE1
Ferreira, LM; Garcia, EB; Montano-Pedroso, JC; Novo, NF; Veiga, DF1
Dorsch, MP; Hanigan, S; Kaminsky, BM; Koelling, TM; Pogue, KT1
Frostad, KB; Johnson, AC; Zager, RA1
Fell, LH; Fliser, D; Heine, GH; Rotter, B; Seiler-Mußler, S; Sellier, AB; Sester, M; Winter, P; Zawada, AM1
Cebrián, C; Deira, J; Fernández-Pereira, L; Gómez-Martino, JR; González-Sanchidrián, S; Jiménez, M; Marín, J; Polanco, S; Tabernero, J1
Macdougall, IC1
Coyne, DW; Daloul, R; Pandey, R1
Kozlovskaya, LV; Markina, MM; Milovanov, YS; Milovanova, SY; Mukhin, NA1
Danko, I; Weidkamp, M1
Gemici, C; Mayadagli, A; Ozden, S; Ozyurt, H; Tepetam, H; Yaprak, G; Yetmen, O1
Aleman, T; Bhuyan, RK; Dunaief, JL; Kanu, LN; Kelly, KL; Li, Y; Morgan, JI; Song, D1
Lopes, AI; Maltez, C; Valério de Azevedo, S1
Donpunha, W; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Sangartit, W; Shibahara, S1
Bansal, SS; Huang, L; Kent, AB; Lee, D; Macdougall, IC; MacGinley, R; McMahon, LP; Roberts, MA; Troster, SM1
Berger, SP; Daha, MR; de Vlaam, TP; Franssen, CF; Gaillard, CA; Gaya da Costa, M; Hempel, JC; Poppelaars, F; Seelen, MA1
Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A1
Achebe, MM; Auerbach, M; Derman, R; Modiano, MR; Roman, E; Thomsen, LL1
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Fishbane, S; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC1
Deverdun, J; Le Bars, E; Menjot de Champfleur, N; Molino, F1
Hamano, H; Hirayama, T; Horinouchi, Y; Ikeda, Y; Ishizawa, K; Izawa-Ishizawa, Y; Kihira, Y; Kishi, S; Miyamoto, L; Nagasawa, H; Oshima, K; Tamaki, T; Tsuchiya, K; Watanabe, H1
Deng, Y; Jia, Q; Wu, J1
Frey, M; Kerrey, BT; Overmann, KM; Richert, A1
Batycky, A; Bernard, K; Dahl, NV; Li, Z; Macdougall, IC; Strauss, WE1
Bhavi, SB; Jaju, PB1
Chow, E; Kaneva, K; Kelly, MJ; Rosenfield, CG1
Delrow, JJ; Johnson, ACM; Zager, RA1
Barea-Mendoza, J; Brashears, SL; Cortés-Puch, I; Kim-Shapiro, DB; Klein, HG; Natanson, C; Perlegas, A; Solomon, SB; Suffredini, DA; Sun, J; Xu, W1
Lee, S; Raw, A; Tyner, K; Zou, P1
Allen, BG; Berg, DJ; Brandt, KE; Buettner, GR; Cullen, JJ; Falls, KC; Fath, MA; Gu, Z; Rodman, SN; Schoenfeld, JD; Spitz, DR; Wagner, BA; Zhan, F1
Atsumi, T; Kitao, N; Miyoshi, H; Nagai, S; Nakamura, A; Nomoto, H; Shimizu, C1
Pai, AB1
Muduma, G; Pollock, RF1
Altaner, C; Altanerova, U; Altanerova, V; Babincova, M; Babinec, P; Benejova, K; Jakubechova, J; Repiska, V; Zduriencikova, M1
Imai, N; Shibagaki, Y; Taki, Y1
Borchard, G; Di Francesco, T; Philipp, E1
Coll, E; Corredor, ZF; Marcos, R; Pastor, S; Rodríguez-Ribera, L; Stoyanova, E1
Borchard, G; Di Francesco, T1
Catarinolo, M; Enzmann, H; Fütterer, S; Langguth, P; Schlösser, C; Schnorr, J; Spicher, K1
Abergel, A; Aumaitre, O; Bagel, S; Boisgard, S; Delpeuch, A; Ruivard, M; Sautou, V1
Cunha, GJL; Menezes Falcão, L; Rocha, BML1
Alcântara Rodrigues de Moraes, M; Bueno Garcia, E; Francescato Veiga, D; Masako Ferreira, L; Montano-Pedroso, JC1
Bai, Z; Feng, R; Guo, X; Hong, C; Qi, X; Romeiro, FG; Xu, X; Zhang, D1
Walther, CP; Winkelmayer, WC; Yan, J1
Butragueño-Laiseca, L; de la Mata Navazo, S; Sánchez Galindo, AC; Santiago Lozano, MJ1

Reviews

39 review(s) available for glucaric acid and ferric oxide, saccharated

ArticleYear
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome

1996
Safety aspects of parenteral iron in patients with end-stage renal disease.
    Drug safety, 1997, Volume: 17, Issue:4

    Topics: Anemia, Iron-Deficiency; Citric Acid; Drug Combinations; Drug Monitoring; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Compounds; Iron Overload; Iron-Dextran Complex; Kidney Failure, Chronic; Sorbitol

1997
Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
    Endocrine journal, 1998, Volume: 45, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Anemia, Refractory; Animals; Calcitriol; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Iatrogenic Disease; Kidney Diseases; Male; Middle Aged; Osteomalacia; Phosphates

1998
[Iron supplementation in preterm infants treated with erythropoietin].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:6

    Topics: Adult; Dietary Supplements; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Kidney Failure, Chronic; Recombinant Proteins

1999
Parenteral iron use in the management of anemia in end-stage renal disease patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:1

    Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis; Recombinant Proteins; Renal Dialysis

2000
Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex.
    The British journal of nutrition, 2002, Volume: 88, Issue:1

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic

2002
Iron sucrose: the oldest iron therapy becomes new.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:6

    Topics: Chronic Disease; Drug Administration Schedule; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Diseases; Treatment Outcome

2002
Clinical review of the newer intravenous iron therapy options.
    Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2003, Volume: 30, Issue:1

    Topics: Anemia, Iron-Deficiency; Clinical Protocols; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Renal Dialysis; Transferrin; Treatment Outcome

2003
[Indications and practical management of parenteral iron therapy].
    Wiener klinische Wochenschrift, 2003, Jun-24, Volume: 115, Issue:11

    Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Child; Erythrocyte Count; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Male; Renal Dialysis; Sucrose; Time Factors; Transferrin

2003
Parenteral iron therapy options.
    American journal of hematology, 2004, Volume: 76, Issue:1

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex

2004
Intravenous iron therapy: well-tolerated, yet not harmless.
    European journal of clinical investigation, 2005, Volume: 35 Suppl 3

    Topics: Anemia; Cytokines; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Neutrophils

2005
Acute injury with intravenous iron and concerns regarding long-term safety.
    Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1 Suppl 1

    Topics: Acute Kidney Injury; Anemia, Iron-Deficiency; Animals; Atherosclerosis; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron-Dextran Complex; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Transferrin

2006
Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease.
    Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1 Suppl 1

    Topics: Acute Kidney Injury; Adenosine Triphosphate; Anemia, Iron-Deficiency; Animals; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Cortex; Kidney Tubules, Proximal; Lipid Peroxidation; Mitochondria; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha

2006
[Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:4

    Topics: Administration, Oral; Anemia, Iron-Deficiency; Diet, Protein-Restricted; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Metabolism Disorders; Iron, Dietary; Kidney Failure, Chronic; Risk Factors; Sex Distribution; Treatment Outcome

2007
[Drug-induced osteomalacia].
    Clinical calcium, 2007, Volume: 17, Issue:10

    Topics: Anticonvulsants; Etidronic Acid; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Osteomalacia

2007
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
    Kidney international, 2008, Volume: 73, Issue:5

    Topics: Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Iron-Dextran Complex; Kidney Diseases

2008
The role of intravenous iron in anemia management and transfusion avoidance.
    Transfusion, 2008, Volume: 48, Issue:5

    Topics: Anemia, Iron-Deficiency; Blood Transfusion; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous

2008
The role of iron supplementation during epoietin treatment for cancer-related anemia.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1

    Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic

2009
Intravenous iron in oncology.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:6

    Topics: Anemia; Antineoplastic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Neoplasms

2008
[Blood conservation approaches in orthopedic surgery].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2008, Volume: 15, Issue:5

    Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction

2008
Iron deficiency anemia: diagnosis and management.
    Current opinion in gastroenterology, 2009, Volume: 25, Issue:2

    Topics: Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Biomarkers; Endoscopy, Digestive System; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepcidins; Humans; Infusions, Parenteral; Iron; Iron Chelating Agents

2009
Intravenous iron in inflammatory bowel disease.
    World journal of gastroenterology, 2009, Oct-07, Volume: 15, Issue:37

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Injections, Intraventricular; Iron; Iron-Dextran Complex; Maltose; Treatment Outcome

2009
A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:2

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis; Renal Insufficiency, Chronic

2011
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:6

    Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism

2013
Is intravenous iron sucrose the treatment of choice for pregnant anemic women?
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:3

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome

2013
[Importance of the different i.v. iron generations for everyday medical practice].
    MMW Fortschritte der Medizin, 2013, Mar-21, Volume: 155 Suppl 1

    Topics: Anemia, Iron-Deficiency; Disaccharides; Dose-Response Relationship, Drug; Drug Substitution; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Structure-Activity Relationship; Treatment Outcome

2013
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24

    Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis

2013
[Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
    Clinical calcium, 2013, Volume: 23, Issue:10

    Topics: Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Osteomalacia; Phosphates; Rickets, Hypophosphatemic

2013
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
    Redox report : communications in free radical research, 2014, Volume: 19, Issue:1

    Topics: Adsorption; Animals; Asbestos; Asbestosis; Benzoates; Carcinogens, Environmental; Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Comparative Genomic Hybridization; Deferasirox; Ferric Compounds; Ferric Oxide, Saccharated; Genes, p16; Glucaric Acid; Humans; Iron Chelating Agents; Iron Overload; Japan; Kidney Neoplasms; Male; Mesothelioma; Mineral Fibers; Peritoneal Neoplasms; Phlebotomy; Pleural Neoplasms; Rats; Triazoles

2014
Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
    Annals of hematology, 2015, Volume: 94, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Birth Weight; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Iron; Pregnancy; Pregnancy Complications, Hematologic; Randomized Controlled Trials as Topic; Treatment Outcome

2015
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14

    Topics: Anemia, Iron-Deficiency; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Deficiencies

2014
Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
    Gynecologic and obstetric investigation, 2015, Volume: 80, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron Compounds; Pregnancy; Pregnancy Complications, Hematologic

2015
[Bone and Nutrition. The relationship between iron and phosphate metabolism].
    Clinical calcium, 2015, Volume: 25, Issue:7

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous; Iron; Osteomalacia; Phosphates; Renal Insufficiency, Chronic; Rickets, Hypophosphatemic

2015
The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015, Volume: 37, Issue:5

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Iron-Dextran Complex; Puerperal Disorders

2015
Iron Treatment Strategies in Nondialysis CKD.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Maltose; Renal Insufficiency, Chronic; Severity of Illness Index; Transferrin

2016
Iron Treatment Strategies in Dialysis-Dependent CKD.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Renal Dialysis; Transferrin

2016
Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
    The AAPS journal, 2017, Volume: 19, Issue:5

    Topics: Colloids; Drug Discovery; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Molecular Weight; Particle Size

2017
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Annals of the New York Academy of Sciences, 2017, Volume: 1407, Issue:1

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron; Nanoparticles; Therapeutic Equivalency; Treatment Outcome

2017
Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
    European journal of internal medicine, 2018, Volume: 52

    Topics: Acute Disease; Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Quality of Life; Renal Insufficiency, Chronic

2018

Trials

140 trial(s) available for glucaric acid and ferric oxide, saccharated

ArticleYear
Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Administration, Oral; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Prosthesis; Humans; Injections, Intravenous; Premedication; Recombinant Proteins; Safety; Treatment Outcome

1996
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome

1996
Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Reticulocyte Count; Sex Characteristics; Treatment Outcome

1996
A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    The Journal of pediatrics, 1996, Volume: 129, Issue:2

    Topics: Administration, Oral; Anemia, Neonatal; Blood Cell Count; Blood Transfusion; Erythrocyte Count; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematocrit; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Lactates; Male; Recombinant Proteins; Reticulocytes

1996
Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:6

    Topics: Adult; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Half-Life; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Receptors, Transferrin; Spectrophotometry, Atomic; Sucrose; Transferrin

1996
Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Nephron, 1996, Volume: 72, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Combinations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Renal Dialysis

1996
Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 1996, Volume: 69, Issue:2

    Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Reference Values; Sucrose; Time Factors

1996
Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:9

    Topics: Adult; Aged; Drug Tolerance; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Transferrin

1996
The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1997, Volume: 13

    Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin

1997
Iron supplementation in haemodialysis--practical clinical guidelines.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:10

    Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Administration Routes; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Support; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Renal Dialysis; Sucrose; Transferrin

1998
Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study.
    Transfusion, 1999, Volume: 39, Issue:5

    Topics: Administration, Oral; Adult; Blood Donors; Blood Transfusion, Autologous; Elective Surgical Procedures; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Tests; Humans; Injections, Intravenous; Male; Postoperative Care; Preoperative Care; Treatment Outcome

1999
Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
    Digestion, 1999, Volume: 60, Issue:3

    Topics: Adult; Anemia, Iron-Deficiency; C-Reactive Protein; Colitis, Ulcerative; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Recombinant Proteins; Reticulocyte Count; Treatment Outcome

1999
Erythropoietic quality of maternal milk.
    Lancet (London, England), 1999, Aug-28, Volume: 354, Issue:9180

    Topics: Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature; Milk, Human; Recombinant Proteins

1999
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:1

    Topics: Anemia, Iron-Deficiency; Blood Pressure; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis

2000
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:11

    Topics: Adult; Aged; Bleomycin; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Staphylococcus epidermidis; Transferrin

2000
Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
    Chang Gung medical journal, 2000, Volume: 23, Issue:10

    Topics: Anemia; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Middle Aged; Recombinant Proteins; Renal Dialysis; Uremia

2000
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pediatrics, 2001, Volume: 107, Issue:1

    Topics: Administration, Oral; Ascorbic Acid; Blood Cell Count; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Malondialdehyde; Prospective Studies; Tyrosine

2001
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:2

    Topics: Aged; Anemia, Iron-Deficiency; Epoetin Alfa; Erythrocyte Indices; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis

2001
Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
    American journal of obstetrics and gynecology, 2001, Volume: 184, Issue:4

    Topics: Anemia, Iron-Deficiency; Erythrocyte Count; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fetal Growth Retardation; Glucaric Acid; Hematocrit; Humans; Placental Insufficiency; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recombinant Proteins; Reticulocyte Count; Transferrin; Treatment Outcome; Ultrasonography

2001
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Clinical nephrology, 2001, Volume: 55, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose

2001
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:5

    Topics: Administration, Oral; Aged; Disease Progression; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency

2001
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:6

    Topics: Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Renal Dialysis; Sucrose; Time Factors; Transferrin

2001
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:8

    Topics: Anemia, Iron-Deficiency; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Interleukin-6; Logistic Models; Male; Prospective Studies; Receptors, Transferrin; ROC Curve; Sensitivity and Specificity; Transferrin; Treatment Outcome

2001
Intravenous iron sucrose: establishing a safe dose.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:5

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Back Pain; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Hypotension; Infusions, Intravenous; Kidney Transplantation; Male; Middle Aged; Nausea; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Renal Insufficiency; Vomiting

2001
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
    The Journal of rheumatology, 2001, Volume: 28, Issue:11

    Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Disability Evaluation; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Status; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Severity of Illness Index; Treatment Outcome

2001
Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo.
    European journal of clinical investigation, 2002, Volume: 32 Suppl 1

    Topics: Adult; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Smoking; Vasodilation

2002
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
    European journal of clinical investigation, 2002, Volume: 32 Suppl 1

    Topics: Anemia; Dialysis Solutions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Protein Binding; Renal Dialysis; Transferrin

2002
Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:3

    Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Birth Weight; Delivery, Obstetric; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Sulfates

2002
Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
    Renal failure, 2002, Volume: 24, Issue:2

    Topics: Aged; Anemia; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis

2002
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:3

    Topics: Anemia, Iron-Deficiency; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Population Surveillance; Treatment Outcome

2003
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Scandinavian journal of urology and nephrology, 2003, Volume: 37, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Erythrocyte Deformability; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Time Factors

2003
Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
    The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Renal Insufficiency; Severity of Illness Index; Time Factors

2003
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.
    Kidney international, 2003, Volume: 64, Issue:2

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Neutrophils; Peritoneal Dialysis; Phagocytosis; Prospective Studies; Respiratory Burst

2003
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease.
    Kidney international. Supplement, 2003, Issue:87

    Topics: Aged; Anemia; Blood Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Transferrin; Treatment Outcome

2003
Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients.
    Kidney international, 2004, Volume: 66, Issue:1

    Topics: Adult; Autoimmune Diseases; Bleomycin; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Parenteral; Iron; Iron Deficiencies; Middle Aged; Plasmapheresis; Serum Albumin; Transferrin

2004
A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anaphylaxis; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Tolerance; Edema; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Thrombophlebitis; Treatment Outcome; Urticaria

2004
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
    Kidney international, 2004, Volume: 66, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sepsis

2004
Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients.
    Nephrology (Carlton, Vic.), 2004, Volume: 9, Issue:4

    Topics: Antioxidants; Cross-Over Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Thiobarbituric Acid Reactive Substances

2004
Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study.
    Transfusion, 2004, Volume: 44, Issue:10

    Topics: Aged; Cross Infection; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intravenous; Iron; Length of Stay; Male; Orthopedic Procedures; Pilot Projects; Postoperative Complications; Preoperative Care

2004
On the nature of proteinuria with acute renal injury in patients with chronic kidney disease.
    American journal of physiology. Renal physiology, 2005, Volume: 288, Issue:2

    Topics: Aged; Albuminuria; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immunoassay; Infusions, Intravenous; Kidney; Kidney Diseases; Kinetics; Male; Oxidation-Reduction; Oxidative Stress; Proteinuria; Sensitivity and Specificity; Serum Albumin

2005
Endothelial injury markers with high-dose intravenous iron therapy in renal failure.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2004, Volume: 10, Issue:4

    Topics: Adult; Aged; Biomarkers; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatocyte Growth Factor; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Renal Insufficiency; Thrombomodulin; Thrombosis; von Willebrand Factor

2004
Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate.
    Nephron. Clinical practice, 2005, Volume: 99, Issue:4

    Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Kidney Failure, Chronic; Male; Parenteral Nutrition; Renal Dialysis

2005
[Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy].
    Annales francaises d'anesthesie et de reanimation, 2005, Volume: 24, Issue:10

    Topics: Anemia; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemodilution; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Postoperative Complications; Reticulocyte Count; Sucrose

2005
Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:2

    Topics: Adult; Aged; Anaphylaxis; Anemia, Hypochromic; Chronic Disease; Cohort Studies; Dysgeusia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Graft Rejection; Humans; Hypotension; Injections, Intravenous; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies

2005
Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Antioxidants; Biomarkers; C-Reactive Protein; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Cross-Over Studies; Feces; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Leukocyte L1 Antigen Complex; Male; Malondialdehyde; Middle Aged; Severity of Illness Index; Treatment Outcome

2005
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:11

    Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies; Transferrin; Treatment Outcome

2005
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
    Kidney international, 2005, Volume: 68, Issue:6

    Topics: Adult; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Forearm; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Prospective Studies; Regional Blood Flow; Vasodilation

2005
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.
    Kidney international, 2005, Volume: 68, Issue:6

    Topics: Administration, Oral; Aged; Anemia; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Patient Compliance; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome

2005
Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2006, Volume: 53, Issue:1

    Topics: Analysis of Variance; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Postoperative Care; Recombinant Proteins; Time Factors; Treatment Outcome

2006
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation

2006
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study.
    Transfusion medicine (Oxford, England), 2006, Volume: 16, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Male; Pilot Projects; Retrospective Studies

2006
[Postpartum and early postoperative anemia after gynecological surgery: treatment with intravenous iron].
    Revista espanola de anestesiologia y reanimacion, 2006, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Prospective Studies; Puerperal Disorders; Sucrose

2006
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:10

    Topics: Aged; CD11b Antigen; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Granulocytes; Hematinics; Humans; Leukocyte Common Antigens; Leukocytes; Lipopolysaccharide Receptors; Luminescence; Male; Middle Aged; Monocytes; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency

2006
Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
    American journal of nephrology, 2006, Volume: 26, Issue:3

    Topics: Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Protein Binding; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Transferrin

2006
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:10

    Topics: Adolescent; Adult; Aged; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis; Transferrin; Treatment Outcome

2006
Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
    Journal of the American College of Cardiology, 2006, Sep-19, Volume: 48, Issue:6

    Topics: Aged; Anemia; Cardiac Output, Low; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Physical Endurance; Prospective Studies; Transferrin; Walking

2006
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
    Transfusion medicine (Oxford, England), 2006, Volume: 16, Issue:5

    Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood Loss, Surgical; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Receptors, Transferrin; Recombinant Proteins; Reticulocyte Count; Treatment Outcome

2006
Intravenous versus oral iron therapy for postpartum anaemia.
    BJOG : an international journal of obstetrics and gynaecology, 2006, Volume: 113, Issue:11

    Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Prospective Studies; Puerperal Disorders

2006
The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
    Blood purification, 2006, Volume: 24, Issue:5-6

    Topics: Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Thiobarbituric Acid Reactive Substances

2006
Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
    Gynecologic oncology, 2007, Volume: 105, Issue:1

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Middle Aged; Prospective Studies; Uterine Cervical Neoplasms

2007
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pharmacotherapy, 2007, Volume: 27, Issue:3

    Topics: Biomarkers; Cross-Over Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Prospective Studies; Renal Dialysis

2007
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:4

    Topics: Aged; Anemia; Antibodies; Aryldialkylphosphatase; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Treatment Outcome

2007
Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
    Journal of cardiac failure, 2007, Volume: 13, Issue:1

    Topics: Adult; Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Prospective Studies; Research Design

2007
Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    Renal failure, 2007, Volume: 29, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intra-Arterial; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged

2007
[Intravenous treatment of postpartum anemia with trivalent ferrum preparation].
    Ceska gynekologie, 2007, Volume: 72, Issue:3

    Topics: Anemia, Iron-Deficiency; Blood Cell Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Puerperal Disorders; Sucrose

2007
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
    Kidney international, 2007, Volume: 72, Issue:5

    Topics: Aged; Cross-Over Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome

2007
Optimum dosage regimen for iron sucrose.
    Kidney international, 2007, Volume: 72, Issue:2

    Topics: Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome

2007
Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:3

    Topics: Anemia, Iron-Deficiency; Darbepoetin alfa; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Peritoneal Dialysis; Recombinant Proteins

2006
Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    American journal of nephrology, 2007, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation Mediators; Infusions, Intravenous; Interleukin-6; Iron-Dextran Complex; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Serum Albumin; Tumor Necrosis Factor-alpha

2007
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Journal of the American College of Cardiology, 2007, Oct-23, Volume: 50, Issue:17

    Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Double-Blind Method; Exercise Tolerance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome

2007
Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
    Clinical therapeutics, 2007, Volume: 29, Issue:12

    Topics: Breath Tests; Cytochrome P-450 Enzyme System; Erythromycin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Deficiencies; Liver; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sucrose

2007
Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Blood purification, 2008, Volume: 26, Issue:2

    Topics: Adult; Aged; Anemia; China; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Treatment Outcome

2008
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome.
    Sleep medicine, 2009, Volume: 10, Issue:2

    Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Restless Legs Syndrome; Substantia Nigra; Treatment Failure

2009
Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients.
    Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:9

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Antioxidants; Deoxyguanosine; DNA Damage; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Lymphocytes; Middle Aged; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Renal Dialysis

2008
The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Renal failure, 2008, Volume: 30, Issue:6

    Topics: Adult; Age Factors; Analysis of Variance; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Probability; Renal Dialysis; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome

2008
A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
    Acta obstetricia et gynecologica Scandinavica, 2008, Volume: 87, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Postpartum Period; Prospective Studies; Quality of Life; Sucrose

2008
Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Journal of renal care, 2008, Volume: 34, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Drug Monitoring; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glomerular Filtration Rate; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Sucrose; Transferrin; Treatment Outcome

2008
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:7

    Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Sweden; Treatment Outcome

2009
Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Acta haematologica, 2009, Volume: 121, Issue:1

    Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Menorrhagia; Middle Aged; Preoperative Care; Prospective Studies

2009
Iron prophylaxis in pregnancy: intravenous route versus oral route.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 144, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Trace Elements; Young Adult

2009
A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jul-30, Volume: 24, Issue:10

    Topics: Adult; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Male; Middle Aged; Restless Legs Syndrome; Surveys and Questionnaires; Time Factors

2009
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:6

    Topics: Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Iron; Male; Prognosis; Prospective Studies; Recurrence; Treatment Outcome

2009
Safety, therapeutic effectiveness, and cost of parenteral iron therapy.
    International journal of hematology, 2009, Volume: 90, Issue:1

    Topics: Adult; Anemia, Iron-Deficiency; Costs and Cost Analysis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Middle Aged

2009
Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
    Vox sanguinis, 2009, Volume: 97, Issue:3

    Topics: Aged; Aged, 80 and over; Ascorbic Acid; Blood Loss, Surgical; Blood Transfusion; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid; Fracture Fixation, Internal; Glucaric Acid; Guideline Adherence; Hip Fractures; Hospitals, University; Humans; Male; Postoperative Complications; Premedication; Prospective Studies; Recombinant Proteins; Retrospective Studies; Vitamin B 12

2009
Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
    Fetal diagnosis and therapy, 2009, Volume: 25, Issue:2

    Topics: Adult; Anemia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Pregnancy; Recombinant Proteins; Treatment Outcome

2009
[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].
    Zhonghua yi xue za zhi, 2009, Feb-24, Volume: 89, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Renal Dialysis

2009
Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery.
    The British journal of surgery, 2009, Volume: 96, Issue:10

    Topics: Adult; Aged; Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Transferrin; Treatment Outcome; Young Adult

2009
Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
    JAMA, 2009, Oct-07, Volume: 302, Issue:13

    Topics: Adult; Altitude; Altitude Sickness; Blood Pressure; Cross-Over Studies; Double-Blind Method; Echocardiography, Doppler; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypertension, Pulmonary; Hypoxia; Iron Deficiencies; Male; Middle Aged; Phlebotomy; Pulmonary Artery; Systole; Young Adult

2009
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:3

    Topics: Administration, Oral; Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Severity of Illness Index

2010
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
    Gynecologic oncology, 2010, Volume: 116, Issue:3

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Taxoids; Young Adult

2010
Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
    Nephrology (Carlton, Vic.), 2010, Volume: 15, Issue:1

    Topics: Anemia; Chlorides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Renal Dialysis

2010
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hemoglobins; Humans; Kidney Diseases; Male; Maltose; Middle Aged; Risk Factors; Sucrose; Treatment Outcome

2010
Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.
    Nephrology (Carlton, Vic.), 2010, Volume: 15, Issue:2

    Topics: Acetylcysteine; Aged; Antioxidants; Biomarkers; CD11b Antigen; CD18 Antigens; Cross-Over Studies; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Inflammation Mediators; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Interleukin-8; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome; von Willebrand Factor

2010
High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.
    Vox sanguinis, 2010, Volume: 99, Issue:4

    Topics: Adult; Age Factors; Blood Donors; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Incidence; Iron; Iron Deficiencies; Male; Middle Aged; Restless Legs Syndrome; Sex Factors

2010
Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial.
    Transfusion, 2011, Volume: 51, Issue:1

    Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intraventricular; Male; Perioperative Period; Postoperative Complications

2011
Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:5

    Topics: Acetylcysteine; Adult; Anemia, Iron-Deficiency; Antioxidants; Biomarkers; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebo Effect; Plethysmography; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome

2010
Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2011, Volume: 6, Issue:1

    Topics: Adult; Aged; Albuminuria; Anemia, Iron-Deficiency; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria

2011
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:2

    Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome

2011
Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2011, Volume: 24, Issue:4

    Topics: Adult; Cross-Over Studies; Cytokines; F2-Isoprostanes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Middle Aged; Molecular Weight; Prospective Studies; Reactive Oxygen Species; Renal Dialysis

2011
Do two intravenous iron sucrose preparations have the same efficacy?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:10

    Topics: Anemia, Iron-Deficiency; Cohort Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Prognosis; Renal Dialysis

2011
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Gastroenterology, 2011, Volume: 141, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Comorbidity; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome; Young Adult

2011
Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.
    Blood, 2011, Sep-22, Volume: 118, Issue:12

    Topics: Adult; Double-Blind Method; Fatigue; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Patient Selection; Placebos; Premenopause; Research Design; Sucrose

2011
Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial.
    High altitude medicine & biology, 2011,Fall, Volume: 12, Issue:3

    Topics: Acute Disease; Adult; Altitude Sickness; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Male; Oxygen; Severity of Illness Index; Sucrose; Young Adult

2011
Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty.
    British journal of anaesthesia, 2012, Volume: 108, Issue:3

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Postoperative Care

2012
Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2012, Volume: 25, Issue:5

    Topics: Adult; Ascorbic Acid; Cross-Over Studies; Cytokines; Epoetin Alfa; Erythropoietin; F2-Isoprostanes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Middle Aged; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Recombinant Proteins; Systems Biology

2012
Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:2

    Topics: Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Iron, Dietary; Pregnancy; Pregnancy Complications; Young Adult

2013
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
    Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:6

    Topics: Administration, Oral; Aged; Analysis of Variance; Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chi-Square Distribution; Double-Blind Method; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Spain; Sucrose; Tablets; Time Factors; Treatment Failure

2012
[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2012, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Young Adult

2012
Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Cross-Sectional Studies; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Liver; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Renal Dialysis

2012
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2013, Volume: 26, Issue:7

    Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Blood Loss, Surgical; Cesarean Section; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Young Adult

2013
Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Peritoneal Dialysis; Prospective Studies; Renal Insufficiency, Chronic; Young Adult

2013
Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
    Pediatrics international : official journal of the Japan Pediatric Society, 2013, Volume: 55, Issue:3

    Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Antioxidants; Child; Child, Preschool; Developing Countries; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycine; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Male; Oxidative Stress; Sucrose; Turkey

2013
IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
    International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Treatment Outcome

2013
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
    American journal of hematology, 2013, Volume: 88, Issue:12

    Topics: Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Darbepoetin alfa; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Quality of Life; Transferrin; Transplantation Conditioning; Transplantation, Autologous

2013
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans.
    European journal of nutrition, 2014, Volume: 53, Issue:2

    Topics: Absorption; Adult; Animals; Body Mass Index; Cross-Over Studies; Double-Blind Method; Drug Compounding; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Food, Fortified; Glucaric Acid; Humans; Iron; Male; Milk; Mouth; Postprandial Period

2014
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome

2014
The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.
    Trials, 2013, Sep-09, Volume: 14

    Topics: Aged; Anemia; Biomarkers; Clinical Protocols; Drug Administration Schedule; England; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Fracture Fixation; Glucaric Acid; Hematinics; Hemoglobins; Hip Fractures; Hospitals, University; Humans; Infusions, Intravenous; Pilot Projects; Postoperative Hemorrhage; Research Design; Reticulocyte Count; Time Factors; Treatment Outcome

2013
Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
    Pediatric hematology and oncology, 2014, Volume: 31, Issue:1

    Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Drug Resistance; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Sucrose; Treatment Outcome

2014
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.
    Gynecologic oncology, 2013, Volume: 131, Issue:3

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Genital Neoplasms, Female; Glucaric Acid; Hematinics; Hemoglobins; Humans; Middle Aged; Paclitaxel

2013
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
    BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:6

    Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Infusions, Intravenous; Iron, Dietary; Puerperal Disorders; Severity of Illness Index; Spain; Treatment Outcome

2014
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
    Clinical journal of the American Society of Nephrology : CJASN, 2014, Volume: 9, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Injections, Intravenous; Least-Squares Analysis; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome

2014
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    American journal of hematology, 2014, Volume: 89, Issue:6

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged

2014
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
    Critical care medicine, 2014, Volume: 42, Issue:9

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; APACHE; Critical Illness; Erythrocyte Transfusion; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male; Middle Aged; Protoporphyrins; Single-Blind Method; Transferrin; Trauma Centers; Young Adult

2014
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.
    Blood cells, molecules & diseases, 2014, Volume: 53, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Cognition; Drug Administration Schedule; Exercise Test; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Male; Psychological Tests; Quality of Life; Walking

2014
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
    Heart, lung & circulation, 2015, Volume: 24, Issue:7

    Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Iron; Iron Deficiencies; Male; Pilot Projects; Renal Insufficiency, Chronic; Ventricular Function, Left

2015
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
    American journal of hematology, 2015, Volume: 90, Issue:7

    Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous

2015
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Early Intervention, Educational; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Maintenance Chemotherapy; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult

2015
A randomized trial of intravenous and oral iron in chronic kidney disease.
    Kidney international, 2015, Volume: 88, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Biomarkers; Disease Progression; Early Termination of Clinical Trials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Indiana; Kidney; Male; Middle Aged; Quality of Life; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome

2015
Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Hematinics; Humans; Postpartum Hemorrhage; Pregnancy; Prevalence; Thromboembolism; Tranexamic Acid; Treatment Outcome; Young Adult

2016
Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, Jul-15, Volume: 21

    Topics: Adult; Altitude Sickness; Dietary Supplements; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies

2015
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
    Gut, 2017, Volume: 66, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Microbiome; Glucaric Acid; Hematinics; Humans; Iron Deficiencies; Metabolome; Quality of Life; RNA, Ribosomal, 16S

2017
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 133, Issue:1

    Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; India; Maltose; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Hemorrhage

2016
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.
    Trials, 2016, Apr-12, Volume: 17

    Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Clinical Protocols; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematopoiesis; Hemoglobins; Humans; Middle Aged; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult

2016
Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
    Renal failure, 2016, Volume: 38, Issue:7

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Hepcidins; Humans; Kidney Failure, Chronic; Maintenance Chemotherapy; Male; Renal Dialysis; Reticulocyte Count; Reticulocytes; Transferrin

2016
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.
    BMC nephrology, 2016, 11-16, Volume: 17, Issue:1

    Topics: Administration, Intravenous; Aged; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic

2016
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    American journal of hematology, 2017, Volume: 92, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Drug Dosage Calculations; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Time Factors; Treatment Outcome; Young Adult

2017
Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Mar-12, Volume: 23

    Topics: Administration, Intravenous; Aged; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Male; Middle Aged; Quality of Life; Renal Dialysis; Restless Legs Syndrome

2017
The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
    BMC nephrology, 2017, 04-03, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Heart; Hematinics; Humans; Kidney Failure, Chronic; Liver; Magnetic Resonance Imaging; Pancreas; Renal Dialysis

2017
Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    BMC pregnancy and childbirth, 2017, May-08, Volume: 17, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome

2017
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
    The Lancet. Haematology, 2018, Volume: 5, Issue:7

    Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Risk Factors; Treatment Outcome; Young Adult

2018

Other Studies

312 other study(ies) available for glucaric acid and ferric oxide, saccharated

ArticleYear
Oral iron therapy with ferrous fumarate and polysaccharide iron complex.
    ANNA journal, 1992, Volume: 19, Issue:3

    Topics: Administration, Oral; Anemia; Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Kidney Diseases; Renal Dialysis

1992
Lipid peroxidation induced "in vivo" by iron-carbohydrate complex in the rat brain cortex.
    Neurochemical research, 1991, Volume: 16, Issue:1

    Topics: Animals; Cerebral Cortex; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Lipid Peroxidation; Male; Methylprednisolone; Penicillamine; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Thiobarbiturates; Vitamin E

1991
[Chronic hemorrhagic iron deficiency. Sources of hemorrhage, blood loss and systematic iron substitution].
    Folia haematologica (Leipzig, Germany : 1928), 1987, Volume: 114, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hypochromic; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemorrhage; Humans; Iron-Dextran Complex; Male; Middle Aged

1987
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.
    American journal of nephrology, 1987, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Alleles; Anemia; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemochromatosis; Humans; Male; Renal Dialysis; Risk; Transfusion Reaction; Uremia

1987
Effects of intravenous administration of iron preparations on the metabolism of phosphorus. Comparative study on 3 iron preparations.
    Fukuoka igaku zasshi = Hukuoka acta medica, 1984, Volume: 75, Issue:6

    Topics: Adult; Aged; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Tubules; Male; Middle Aged; Parathyroid Hormone; Phosphorus

1984
Different actions of deferoxamine and iron on Ga-67 abscess detection in rats.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1984, Volume: 25, Issue:6

    Topics: Abscess; Animals; Deferoxamine; Drug Evaluation, Preclinical; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gallium Radioisotopes; Glucaric Acid; Iron; Radionuclide Imaging; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution

1984
[Relative Ga-67 image enhancement by iron-loading].
    Kaku igaku. The Japanese journal of nuclear medicine, 1984, Volume: 21, Issue:7

    Topics: Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Ferric Compounds; Ferric Oxide, Saccharated; Gallium Radioisotopes; Glucaric Acid; Humans; Image Enhancement; Iron; Lung Neoplasms; Mice; Neoplasms, Experimental; Rabbits; Radionuclide Imaging; Tissue Distribution

1984
[A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1982, Volume: 56, Issue:3

    Topics: Anemia; Culture Media; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Legionella

1982
Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
    Klinische Wochenschrift, 1983, Jan-17, Volume: 61, Issue:2

    Topics: Anemia, Hypochromic; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Intestinal Absorption; Iron; Kidney; Phosphates

1983
Enhancing effect of saccharated ferric oxide on human lymphocyte transformation in serum-free medium.
    The Tohoku journal of experimental medicine, 1982, Volume: 136, Issue:4

    Topics: Cells, Cultured; DNA Replication; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Lymphocyte Activation

1982
[2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1982, Volume: 71, Issue:11

    Topics: Adult; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Intestinal Diseases; Intestine, Small; Iron; Middle Aged; Osteomalacia; Ulcer

1982
[Response of omental milk spots to colloidal saccharated ferric oxide in the mouse: light and electron microscopic study (author's transl)].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1981, Volume: 56, Issue:2

    Topics: Adipose Tissue; Animals; Colloids; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Lymphoid Tissue; Macrophages; Male; Mice; Omentum; Time Factors

1981
[Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate].
    Biulleten' eksperimental'noi biologii i meditsiny, 1994, Volume: 118, Issue:7

    Topics: Anemia, Iron-Deficiency; Animals; Dextrans; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Intracellular Membranes; Kupffer Cells; Lysosomes; Microscopy, Electron; Rabbits

1994
Biological markers of oxidative stress induced by ethanol and iron overload in rat.
    International journal of occupational medicine and environmental health, 1994, Volume: 7, Issue:4

    Topics: Animals; Biomarkers; Ethanol; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Vitamin E

1994
[A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1994, Volume: 31, Issue:10

    Topics: Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous

1994
Effect of 21-aminosteroid U74500A (pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(5,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methyl-, HCl (16 alpha)) on rat brain cortex lipid peroxidation induced "in vivo" by iron-carbohydrate.
    Biochemical pharmacology, 1994, Jun-15, Volume: 47, Issue:12

    Topics: Animals; Antioxidants; Cerebral Cortex; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Lipid Peroxidation; Pregnatrienes; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances

1994
Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
    American journal of hematology, 1993, Volume: 43, Issue:1

    Topics: Adult; Anemia; Duodenal Ulcer; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iatrogenic Disease; Malabsorption Syndromes; Middle Aged; Osteomalacia

1993
Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
    European journal of haematology, 1993, Volume: 51, Issue:1

    Topics: Anemia; Arthritis, Rheumatoid; C-Reactive Protein; Drug Administration Schedule; Erythrocyte Count; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Time Factors

1993
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors

1996
Effects of iron salts in sucrose on dental caries and plaque in rats.
    Archives of oral biology, 1997, Volume: 42, Issue:5

    Topics: Acids; Anemia, Iron-Deficiency; Animals; Crystallization; Dental Caries; Dental Plaque; Diet, Cariogenic; Dietary Sucrose; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycerophosphates; Hydrogen-Ion Concentration; Incidence; Prevalence; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salivary Glands; Tooth Discoloration

1997
The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:8

    Topics: Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Male; Methods; Middle Aged; Recombinant Proteins; Renal Dialysis; Sensitivity and Specificity; Transferrin

1997
[Parenteral iron replacement].
    Praxis, 1997, May-14, Volume: 86, Issue:20

    Topics: Administration, Oral; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex

1997
Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
    The Journal of laboratory and clinical medicine, 1997, Volume: 130, Issue:4

    Topics: Anemia; Arthritis, Rheumatoid; Blood Donors; Blood Transfusion, Autologous; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Recombinant Proteins

1997
Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:12

    Topics: Administration, Oral; Adult; Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Male; Middle Aged; Renal Dialysis; Retreatment; Treatment Outcome

1997
[Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents].
    Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 1998, Volume: 84, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Anemia; Blood Loss, Surgical; Child; Child, Preschool; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Postoperative Complications; Spinal Fusion; Sucrose

1998
Gelatinous bone marrow transformation complicated by self-induced malnutrition.
    Acta haematologica, 1998, Volume: 100, Issue:2

    Topics: Anorexia Nervosa; Bone Marrow; Citric Acid; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Nutrition Disorders; Treatment Outcome

1998
Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.
    British journal of haematology, 1999, Volume: 104, Issue:2

    Topics: Bone Marrow; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Liver; Sucrose; Tomography, Emission-Computed

1999
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
    British journal of haematology, 1999, Volume: 104, Issue:2

    Topics: Adult; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Male; Middle Aged; Sucrose; Tomography, Emission-Computed; Transferrin

1999
Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
    The British journal of dermatology, 1999, Volume: 140, Issue:4

    Topics: Anemia, Iron-Deficiency; Child; Epidermolysis Bullosa Dystrophica; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Recombinant Proteins; Sucrose

1999
Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats.
    Renal failure, 1999, Volume: 21, Issue:5

    Topics: Administration, Oral; Adsorption; Animals; Calcium; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Phosphates; Random Allocation; Rats; Rats, Wistar; Structure-Activity Relationship; Sucrose; Time Factors

1999
Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glutathione Peroxidase; Humans; Injections, Intravenous; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Reference Values; Renal Dialysis; Superoxide Dismutase

1999
Quantification aspects of patient studies with 52Fe in positron emission tomography.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 1999, Volume: 51, Issue:6

    Topics: Adult; Bone Marrow; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart; Humans; Iron Radioisotopes; Liver; Myocardium; Phantoms, Imaging; Radiopharmaceuticals; Spleen; Tissue Distribution; Tomography, Emission-Computed

1999
Improved response to erythropoietin therapy with long-term continuous iron supplementation.
    Nephron, 2000, Volume: 84, Issue:2

    Topics: Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis

2000
Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
    Acta obstetricia et gynecologica Scandinavica, 2000, Volume: 79, Issue:8

    Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Outcome

2000
[Iron deficiency. When parenteral substitution?].
    MMW Fortschritte der Medizin, 2001, Feb-08, Volume: 143, Issue:6

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron

2001
Iron sucrose or ferric gluconate?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:6

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Renal Dialysis; Sucrose; Terminology as Topic

2001
[Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation].
    Annales francaises d'anesthesie et de reanimation, 2002, Volume: 21, Issue:1

    Topics: Adult; Anemia, Iron-Deficiency; Autoantibodies; Blood Preservation; Blood Transfusion, Autologous; Cryopreservation; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Complications, Hematologic

2002
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2001, Volume: 21 Suppl 3

    Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose

2001
Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment.
    Artificial organs, 2001, Volume: 25, Issue:11

    Topics: Adult; Bacterial Infections; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Middle Aged; Renal Dialysis; Sucrose

2001
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:1

    Topics: Animals; Aorta; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Chlorides; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oligosaccharides; Oxidants; Parenteral Nutrition

2002
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
    Clinical nephrology, 2002, Volume: 58 Suppl 1

    Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Oxygen Consumption; Recombinant Proteins; Stroke Volume

2002
Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
    Clinical nutrition (Edinburgh, Scotland), 2002, Volume: 21, Issue:5

    Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Infusions, Intravenous; Iron; Parenteral Nutrition; Reticulocyte Count; Time Factors

2002
Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:5

    Topics: Aged; Aged, 80 and over; Blood Proteins; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glycation End Products, Advanced; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Sodium Chloride; Sucrose

2002
Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:5

    Topics: Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Tubules; Lipid Peroxidation; Oxidative Stress; Renal Dialysis

2002
Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
    JPMA. The Journal of the Pakistan Medical Association, 2002, Volume: 52, Issue:9

    Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intramuscular; Injections, Intravenous; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome

2002
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:2

    Topics: Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recombinant Proteins; Renal Dialysis; Reticulocyte Count; Reticulocytes

2003
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
    British journal of haematology, 2003, Volume: 120, Issue:5

    Topics: Adult; Aged; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron Radioisotopes; Liver; Male; Middle Aged; Reticulocyte Count; Spleen; Tomography, Emission-Computed

2003
Safety issues with iron sucrose.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:4

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Safety; Superoxides; Transferrin; Vasodilation

2003
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose

2003
Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-01, Volume: 37, Issue:5

    Topics: Aged; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Male; Ostreidae; Renal Dialysis; Sucrose; Vibrio Infections; Vibrio vulnificus

2003
Intravenous iron therapy with saccharated iron oxide.
    The Indian medical gazette, 1952, Volume: 87, Issue:7

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds

1952
[Hematological response of pregnant to saccharated iron oxide].
    El Dia medico, 1952, Aug-28, Volume: 24, Issue:55

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds; Pregnancy; Pregnancy Complications

1952
Histological appearances following intravenous saccharated iron oxide, and the factors governing precipitation of the compound in vivo.
    Guy's Hospital reports, 1953, Volume: 102, Issue:2

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds

1953
Experimental investigations on saccharated iron oxide.
    Acta Societatis Medicorum Upsaliensis, 1953, Volume: 58, Issue:1-2

    Topics: Blood; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds

1953
[Problem of the blood pressure reduction by iron saccharates].
    Arzneimittel-Forschung, 1953, Volume: 3, Issue:3

    Topics: Blood Pressure; Carbohydrates; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Iron

1953
[Problem of the blood pressure reduction by iron saccharates].
    Arzneimittel-Forschung, 1953, Volume: 3, Issue:3

    Topics: Blood Pressure; Carbohydrates; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Iron

1953
[The behavior of iron saccharates in the body and its therapeutic significance].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1953, Volume: 217, Issue:5

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1953
[Iron saccharate tolerance tests].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1953, Volume: 218, Issue:1-2

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1953
Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations.
    British medical journal, 1954, Feb-13, Volume: 1, Issue:4858

    Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Male

1954
[The dosage of intravenous colloidal iron saccharates].
    Munchener medizinische Wochenschrift (1950), 1954, Feb-19, Volume: 96, Issue:8

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1954
[Hemoglobin level in normal pregnancy after injection of colloidal iron saccharate].
    Nordisk medicin, 1954, Apr-29, Volume: 51, Issue:18

    Topics: Anemia; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Iron; Pregnancy

1954
[Stimulating effect of colloidal iron saccharates on bone marrow].
    Arztliche Forschung, 1954, Jun-10, Volume: 8, Issue:6

    Topics: Bone Marrow; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1954
[Effect of experimental block of reticuloendothelial system with trypan blue and iron saccharate on anoxemic resistance in rat].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1954, Volume: 221, Issue:5

    Topics: Animals; Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hypoxia; Iron; Mononuclear Phagocyte System; Rats; Trypan Blue

1954
[Measurement of the granulopectic activity of the reticuloendothelial system of the rat by means of saccharated iron oxide].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1954, Volume: 148, Issue:5-6

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Mononuclear Phagocyte System; Rats

1954
Iron therapy in pregnancy; a comparative study of various modes.
    California medicine, 1954, Volume: 81, Issue:5

    Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications

1954
Glomerular lesions and the nephrotic syndrome in rabbits given saccharated iron oxide intravenously; with special reference to the part played by intracapillary precipitates in the pathogenesis of the lesions.
    The Journal of experimental medicine, 1956, Jan-01, Volume: 103, Issue:1

    Topics: Animals; Capillaries; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney; Kidney Diseases; Kidney Glomerulus; Nephrosis; Nephrotic Syndrome; Proteinuria; Rabbits

1956
[Knowledge on injectible saccharated ferric oxide].
    Dansk tidsskrift for farmaci, 1956, Sep-22, Volume: 30, Issue:Suppl 2

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Knowledge

1956
[Injectable iron-oxide-sucrose].
    Pharmaceutica acta Helvetiae, 1956, Volume: 31, Issue:10

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Oxides; Sucrose

1956
[Effect of the injection of saccharated iron oxide on the phagocytic activity of the reticuloendothelial system in the rat].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1956, Nov-18, Volume: 150, Issue:6

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Mononuclear Phagocyte System; Phagocytosis; Rats

1956
[Information on injectable saccharated ferric oxide].
    Pharmaceutica acta Helvetiae, 1956, Volume: 31, Issue:11

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1956
[Metabolism of radioiron-labeled, colloidal iron saccharate in man].
    Strahlentherapie, 1956, Volume: Sonderbd 36

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron

1956
[Experimental study with animals on injuries of the organ after administration of iron sucroses].
    Zeitschrift fur die gesamte experimentelle Medizin, 1956, Volume: 128, Issue:2

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Siderosis

1956
The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy.
    The Journal of experimental medicine, 1959, Feb-01, Volume: 109, Issue:2

    Topics: Animals; Animals, Laboratory; Cytoplasm; Electrons; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemosiderin; Injections, Intraperitoneal; Iron; Liver; Macrophages; Mice; Microscopy; Microscopy, Electron; Pigments, Biological; Spleen

1959
Staining of the retina with saccharated iron oxide.
    A.M.A. archives of ophthalmology, 1959, Volume: 61, Issue:5

    Topics: Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Retina; Staining and Labeling

1959
Staining of fungi with saccharated iron oxide.
    Stain technology, 1959, Volume: 34, Issue:3

    Topics: Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fungi; Glucaric Acid; Iron; Staining and Labeling

1959
Intranuclear aggregates of ferritin in liver cells of mice treated with saccharated iron oxide. Their possible relation to nuclear protein synthesis.
    The Journal of biophysical and biochemical cytology, 1961, Volume: 9

    Topics: Animals; Cell Nucleus; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hepatocytes; Iron; Liver; Mice; Mice, Inbred DBA; Nuclear Proteins; Protein Biosynthesis

1961
The reticuloendothelial system in the rabbit. Phagocytosis of saccharated iron oxide.
    Archives of pathology, 1961, Volume: 72

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Mononuclear Phagocyte System; Phagocytosis; Rabbits

1961
[On the problem of the effect of feeding of iron saccharate on the mutation rate induced by roentgen rays in Drosophila melanogaster].
    Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova, 1960, Volume: 91

    Topics: Animals; Carbohydrates; Drosophila melanogaster; Ferric Compounds; Ferric Oxide, Saccharated; Genetics; Glucaric Acid; Iron; Mutation Rate; X-Rays

1960
Experimental production of cholangitis and pancreatitis by ferric oxide saccharate (Fe-OS).
    The American journal of gastroenterology, 1962, Volume: 38

    Topics: Cholangitis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Pancreatitis

1962
DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED SACCHARATED IRON OXIDE IN THE POPLITEAL LYMPH NODE OF THE RABBIT.
    Nature, 1964, Jul-18, Volume: 203

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Lymph Nodes; Lymphocytes; Physiology; Rabbits; Research

1964
[Velocity of disappearance in plasma of saccharated iron oxide administered intravenously].
    Clinica nuova; rassegna del progresso medico internazionale, 1954, Dec-11, Volume: 19, Issue:23

    Topics: Cardiovascular System; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Function Tests; Humans; Iron; Plasma

1954
Infusion of saccharated iron oxide in the treatment of iron deficiency anemia.
    North Carolina medical journal, 1962, Volume: 23

    Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; North Carolina

1962
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
    Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:3

    Topics: Anemia; Chronic Disease; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Radiation Injuries; Recombinant Proteins; Reticulocyte Count

2003
[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
    Terapevticheskii arkhiv, 2003, Volume: 75, Issue:8

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Sucrose; Treatment Outcome

2003
Achieving optimal patient outcomes with intravenous iron.
    Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2003, Volume: 30, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Nurse-Patient Relations; Time Factors; Treatment Outcome

2003
Reactivity of iron compounds.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 42, Issue:5

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Mice

2003
Pharmacokinetics and utilization of iron sucrose.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 42, Issue:5

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kupffer Cells; Tissue Distribution

2003
[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
    Akusherstvo i ginekologiia, 2003, Volume: 42 Suppl 2

    Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heparin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sucrose

2003
Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.
    Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2003, Volume: 30, Issue:5

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis

2003
Effect of iron sucrose on human peritoneal mesothelial cells.
    European journal of clinical investigation, 2003, Volume: 33, Issue:12

    Topics: Cell Division; Cell Survival; Cells, Cultured; Dialysis Solutions; Drug Interactions; Epithelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Humans; Interleukin-6; Peritoneal Cavity

2003
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study.
    BMC nephrology, 2004, Jan-12, Volume: 5

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemodialysis Solutions; Iron; Iron-Dextran Complex; Membranes, Artificial; Renal Dialysis

2004
Labile iron in parenteral iron formulations: a quantitative and comparative study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:3

    Topics: Biological Assay; Chemistry, Pharmaceutical; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Protein Binding; Sucrose; Transferrin

2004
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
    Canadian Medical Association journal, 1951, Volume: 64, Issue:1

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1951
Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity.
    Canadian Medical Association journal, 1951, Volume: 64, Issue:1

    Topics: Blood; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Tests; Humans; Injections, Intravenous; Iron

1951
[Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
    Zentralblatt fur Gynakologie, 1951, Volume: 73, Issue:11

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron

1951
Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
    Blood, 1951, Volume: 6, Issue:11

    Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron; Obstetrics; Pregnancy

1951
[Colorimetric determination of iron in colloid iron-saccharate solutions].
    Munchener medizinische Wochenschrift (1950), 1952, Feb-01, Volume: 94, Issue:5

    Topics: Colloids; Colorimetry; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds

1952
The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
    Surgery, gynecology & obstetrics, 1952, Volume: 94, Issue:5

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds; Pregnancy

1952
[Constitution of ferri-3-saccharate].
    Pharmaceutica acta Helvetiae, 1951, Volume: 26, Issue:12

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds

1951
The immediate hematologic effects of intravenous saccharated iron oxide.
    Blood, 1952, Volume: 7, Issue:9

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds; Leukocytes

1952
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
    Nephron. Clinical practice, 2004, Volume: 96, Issue:2

    Topics: Anemia, Iron-Deficiency; Diarrhea; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Infusions, Intravenous; Male; Nausea; Prospective Studies; Renal Dialysis; Vomiting

2004
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:4

    Topics: Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Nandrolone; Nandrolone Decanoate; Sucrose

2004
Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:6

    Topics: Blotting, Western; Cell Line; Citric Acid; Electrophoresis, Polyacrylamide Gel; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fluoresceins; Glucaric Acid; Humans; Iron; Oxidative Stress; Peroxides; Quaternary Ammonium Compounds; Renal Dialysis; Time Factors; Transferrin; Urea

2004
Treatment of anaemia in inflammatory bowel disease with iron sucrose.
    Scandinavian journal of gastroenterology, 2004, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Retrospective Studies; Sucrose; Treatment Outcome

2004
Parenteral iron nephrotoxicity: potential mechanisms and consequences.
    Kidney international, 2004, Volume: 66, Issue:1

    Topics: Animals; Cell Line; Cytochromes c; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; In Vitro Techniques; Infusions, Parenteral; Iron; Iron-Dextran Complex; Kidney; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Microscopy, Electron; RNA, Messenger; Severity of Illness Index

2004
Transferrin saturation with intravenous irons: an in vitro study.
    Kidney international, 2004, Volume: 66, Issue:3

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; In Vitro Techniques; Infusions, Intravenous; Iron; Iron-Dextran Complex; Titrimetry; Transferrin

2004
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 44, Issue:3

    Topics: Adult; Aged; Darbepoetin alfa; Enoxaparin; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Agents; Humans; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis

2004
Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.
    Clinical nephrology, 2004, Volume: 62, Issue:2

    Topics: Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron Deficiencies; Jehovah's Witnesses; Kidney Diseases; Middle Aged; Severity of Illness Index; Time Factors

2004
[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].
    Medicina clinica, 2004, Sep-11, Volume: 123, Issue:8

    Topics: Aged; Aged, 80 and over; Anemia; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Iron; Male; Sucrose

2004
[Cooley's syndrome in the adult: treatment with intravenous iron saccharate].
    La Semana medica, 1950, May-04, Volume: 57, Issue:18

    Topics: Adult; Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1950
Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose.
    Renal failure, 2004, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Biomarkers; Blood Chemical Analysis; Case-Control Studies; Chi-Square Distribution; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Reference Values; Renal Dialysis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Troponin T

2004
[Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
    Nihon Jinzo Gakkai shi, 2004, Volume: 46, Issue:8

    Topics: Aged; Anemia, Iron-Deficiency; Ascorbic Acid; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome

2004
[How to avoid a haemotransfusion which is not lifesaving? (our experience with administration of intravenous iron to pregnant women and young mothers)].
    Akusherstvo i ginekologiia, 2004, Volume: 43, Issue:6

    Topics: Anemia, Iron-Deficiency; Blood Transfusion; Drug Administration Schedule; Erythrocyte Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Sucrose

2004
Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
    Archives of orthopaedic and trauma surgery, 2005, Volume: 125, Issue:5

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Prospective Studies

2005
Intravenous iron in a primary-care clinic.
    American journal of hematology, 2005, Volume: 78, Issue:4

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Renal Insufficiency; Sucrose

2005
Hypersensitivity reactions and deaths associated with intravenous iron preparations.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7

    Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Anaphylaxis; Drug Hypersensitivity; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Retrospective Studies; Severity of Illness Index; Sucrose; United States

2005
Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients.
    Kidney international, 2005, Volume: 68, Issue:1

    Topics: Anemia; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis

2005
Ironing out the mystery of nephrotoxicity of parenteral iron.
    The Journal of laboratory and clinical medicine, 2005, Volume: 146, Issue:1

    Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron-Dextran Complex; Kidney Diseases; Kidney Tubules; Oxidative Stress

2005
Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats.
    The Journal of laboratory and clinical medicine, 2005, Volume: 146, Issue:1

    Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Creatinine; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Iron-Dextran Complex; Kidney; Male; Organ Size; Phosphorus; Rats; Rats, Sprague-Dawley; Serum Albumin; Sodium

2005
Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:4

    Topics: Anemia, Iron-Deficiency; Chemical and Drug Induced Liver Injury; Child, Preschool; Deferoxamine; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Humans; Infusions, Intravenous; Liver Diseases; Male; Siderophores; Treatment Outcome

2005
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
    Kidney international, 2005, Volume: 68, Issue:4

    Topics: Acute Disease; Animals; Cells, Cultured; Chemokine CCL2; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression; Glucaric Acid; Gluconates; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Cortex; Kidney Diseases; Liver; Male; Mice; Mice, Inbred Strains; Oxidative Stress; Peritoneum; RNA, Messenger

2005
Trends in intravenous iron use among dialysis patients in the United States (1994-2002).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hypochromic; Child; Child, Preschool; Drug Utilization; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Incidence; Infant; Infusions, Intravenous; Kidney Failure, Chronic; Male; Medicare; Middle Aged; Outpatients; Peritoneal Dialysis; Prevalence; Recombinant Proteins; Renal Dialysis; Retrospective Studies; United States

2005
Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
    Nephrology (Carlton, Vic.), 2005, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver; Male; Middle Aged; Renal Dialysis; Retrospective Studies

2005
Update on adverse drug events associated with parenteral iron.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Sucrose

2006
Parenteral iron therapy: a single institution's experience over a 5-year period.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2005, Volume: 3, Issue:6

    Topics: Acetaminophen; Anemia, Iron-Deficiency; Diphenhydramine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Parenteral; Iron Metabolism Disorders; Iron-Dextran Complex; Kidney Diseases; Male; Menorrhagia; Neoplasms; Premedication; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; United States; von Willebrand Diseases

2005
Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Volume: 123 Suppl 2

    Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic

2005
Intravenous iron in the treatment of anemia of pregnancy. 1949.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Volume: 123 Suppl 2

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; History, 20th Century; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic

2005
Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
    Acta paediatrica (Oslo, Norway : 1992), 2005, Volume: 94, Issue:12

    Topics: Anemia; Child; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Prospective Studies; Recombinant Proteins

2005
Re: blood transfusion and orthognathic surgery a thing of the past?
    The British journal of oral & maxillofacial surgery, 2006, Volume: 44, Issue:5

    Topics: Blood Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Oral Surgical Procedures; Sucrose

2006
Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study.
    European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:4

    Topics: Anemia, Refractory; C-Reactive Protein; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Interleukin-6; Male; Pilot Projects; Receptors, Transferrin; Transferrin; Treatment Outcome

2006
Proinflammatory effects of iron sucrose in chronic kidney disease.
    Kidney international, 2006, Volume: 69, Issue:7

    Topics: Aged; Chemokine CCL2; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammation; Kidney Diseases; Kidney Failure, Chronic; Reproducibility of Results

2006
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
    European journal of heart failure, 2006, Volume: 8, Issue:5

    Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines

2006
Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:11

    Topics: Animals; Apoptosis; Cattle; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron-Dextran Complex; Signal Transduction; Stress, Physiological

2006
Is i.v. iron really superior in CKD patients not on dialysis?
    Kidney international, 2006, Volume: 70, Issue:6

    Topics: Administration, Oral; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Hypotension; Injections, Intravenous; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome

2006
Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
    Clinical nephrology, 2006, Volume: 66, Issue:5

    Topics: Aged; Anemia, Iron-Deficiency; Bacteremia; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Poisson Distribution; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Statistics, Nonparametric

2006
Iron sucrose induced morphological and functional changes in the rat kidney.
    Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:5

    Topics: Albuminuria; Animals; Body Weight; Creatinine; Diuresis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Kidney; Male; Rats; Rats, Wistar; Urea

2006
[Use of Venofer in management of anemia in cancer patients].
    Voprosy onkologii, 2006, Volume: 52, Issue:5

    Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome

2006
[Ferropenic anemia: some comments].
    Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20

    Topics: Anemia, Iron-Deficiency; Celiac Disease; Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid Deficiency; Glucaric Acid; Humans; Injections, Intravenous; Iron; Sucrose

2006
[Budget impact analysis of a blood saving program for urgent traumatological surgery].
    Medicina clinica, 2007, Jan-13, Volume: 128, Issue:1

    Topics: Administration, Oral; Age Factors; Aged, 80 and over; Anemia; Budgets; Confidence Intervals; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Iron; Length of Stay; Male; Recombinant Proteins

2007
Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex.
    Journal of perinatal medicine, 2007, Volume: 35, Issue:2

    Topics: Adult; Anemia, Iron-Deficiency; Breast Feeding; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron; Iron Deficiencies; Milk, Human; Postpartum Period; Puerperal Disorders

2007
Coronary artery vasospasm with iron sucrose.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:6

    Topics: Coronary Vasospasm; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Myocardial Ischemia

2007
[Treatments of the martial deficiencies: preparations available in France].
    Nephrologie & therapeutique, 2006, Volume: 2 Suppl 5

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Iron; Iron Deficiencies

2006
Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
    Pharmacotherapy, 2007, Volume: 27, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hispanic or Latino; Humans; Infusions, Intravenous; Injections, Intravenous; Self Administration; Treatment Outcome

2007
[Current recommendations for the treatment of iron deficiency anemia].
    Revue medicale suisse, 2007, Apr-04, Volume: 3, Issue:105

    Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Therapy, Combination; Epoetin Alfa; Erythrocyte Count; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Sucrose; Switzerland; Transferrin

2007
Peritoneal effects of intravenous iron sucrose administration in rats.
    Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 149, Issue:6

    Topics: Animals; Cells, Cultured; Dialysis Solutions; Drug Therapy, Combination; Eosinophils; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Hematinics; Infusions, Intravenous; Iron; Leukocytes; Lipopolysaccharides; Macrophages, Peritoneal; Male; Pancreatic Elastase; Peritoneal Dialysis; Peritoneum; Peritonitis; Permeability; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2007
Intravenous iron.
    The New England journal of medicine, 2007, Jul-05, Volume: 357, Issue:1

    Topics: Anemia; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Molecular Weight; Renal Dialysis; United States; United States Food and Drug Administration

2007
The safety of intravenous iron sucrose use in the elderly patient.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2007, Volume: 22, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Geriatrics; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis

2007
Blood conservation in the critically ill.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Aug-15, Volume: 64, Issue:16 Suppl 1

    Topics: Adult; Aged; Anemia; Baltimore; Blood; Blood Chemical Analysis; Clinical Protocols; Critical Care; Critical Illness; Drug Costs; Drug Monitoring; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pilot Projects; Recombinant Proteins

2007
Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88 Suppl 2

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Postpartum Period; Pregnancy; Prevalence

2005
Anemia and heart failure a new pathway?
    Journal of the American College of Cardiology, 2007, Oct-23, Volume: 50, Issue:17

    Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome

2007
Chemical reactions of vitamin C with intravenous-iron formulations.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:1

    Topics: Animals; Ascorbic Acid; Cattle; Drug Interactions; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous

2008
Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Renal failure, 2007, Volume: 29, Issue:7

    Topics: Adult; Aged; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glutathione Peroxidase; Humans; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Sucrose

2007
Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
    Translational research : the journal of laboratory and clinical medicine, 2008, Volume: 151, Issue:1

    Topics: Animals; Body Weight; Carcinoma, Hepatocellular; Cell Line, Tumor; Chick Embryo; Embryo, Nonmammalian; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Iron-Dextran Complex; Kidney; Liver; Liver Neoplasms; Nanoparticles; Survival Rate; Turkeys

2008
Preparation and standardization of saccharated iron oxide for intra venous administration.
    Lancet (London, England), 1949, Apr-23, Volume: 1, Issue:6556

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Reference Standards

1949
Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Jan-15, Volume: 65, Issue:2

    Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Male

2008
Intravenous treatment of anaemia with an iron-sucrose preparation.
    Lancet (London, England), 1949, Jan-01, Volume: 1, Issue:6540

    Topics: Anemia; Anemia, Sickle Cell; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Sucrose

1949
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
    Kidney international, 2008, Volume: 73, Issue:4

    Topics: Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Kidney Diseases; Male; Proteinuria; Renal Dialysis

2008
A permanent tan from iron.
    Kidney international, 2008, Volume: 73, Issue:7

    Topics: Aged; Anemia, Iron-Deficiency; Arm; Extravasation of Diagnostic and Therapeutic Materials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hyperpigmentation

2008
Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery.
    Anesthesiology, 2008, Volume: 109, Issue:1

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Orthopedic Procedures; Preoperative Care

2008
Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
    The Israel Medical Association journal : IMAJ, 2008, Volume: 10, Issue:5

    Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome

2008
Parenteral iron therapy.
    The Israel Medical Association journal : IMAJ, 2008, Volume: 10, Issue:5

    Topics: Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Infusions, Parenteral; Iron; Patient Compliance

2008
Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection.
    Free radical biology & medicine, 2008, Nov-01, Volume: 45, Issue:9

    Topics: Adult; Aged; Catalysis; Electron Spin Resonance Spectroscopy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Hematinics; Humans; Iron; Lipoproteins, LDL; Male; Middle Aged; Models, Biological; Oxidative Stress

2008
Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2008, Volume: 24

    Topics: Brachial Artery; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Ultrasonography; Vasodilation

2008
Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
    Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:3

    Topics: Aged; Anemia, Iron-Deficiency; Centers for Medicare and Medicaid Services, U.S.; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; United States

2009
Use of iron sucrose in dialysis patients sensitive to iron dextran.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2009, Volume: 20, Issue:2

    Topics: Adult; Aged; Anemia, Iron-Deficiency; Dialysis Solutions; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Young Adult

2009
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    BMC nephrology, 2009, Feb-26, Volume: 10

    Topics: Adult; Aged; Anemia; Comorbidity; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Survival Analysis; Transferrin

2009
[Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients].
    Medicina clinica, 2009, Mar-07, Volume: 132, Issue:8

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Male; Middle Aged; Preoperative Care; Prospective Studies

2009
Intravenous iron sucrose changes the intraperitoneal homeostasis.
    Blood purification, 2009, Volume: 28, Issue:1

    Topics: Adult; Aged; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dialysis Solutions; Endothelium; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Interleukin-6; Iron; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Permeability; Uremia

2009
Treatment of restless legs syndrome with iron infusion therapy.
    JAAPA : official journal of the American Academy of Physician Assistants, 2009, Volume: 22, Issue:3

    Topics: Continuous Positive Airway Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Middle Aged; Restless Legs Syndrome; Sleep Apnea, Obstructive

2009
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Journal of renal care, 2009, Volume: 35, Issue:2

    Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sucrose

2009
Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Jun-15, Volume: 66, Issue:12

    Topics: Adult; Anemia; Cohort Studies; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Renal Dialysis; Retrospective Studies; Transferrin

2009
Differences between original intravenous iron sucrose and iron sucrose similar preparations.
    Arzneimittel-Forschung, 2009, Volume: 59, Issue:4

    Topics: Animals; Biomarkers; Blood Pressure; Chemistry, Pharmaceutical; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Heart; Hematinics; Hemodynamics; Immunohistochemistry; Inflammation; Injections, Intravenous; Kidney; Liver; Male; Myocardium; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley

2009
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Bone, 2009, Volume: 45, Issue:4

    Topics: Adult; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous; Male; Middle Aged

2009
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical ou
    Journal of cardiac failure, 2009, Volume: 15, Issue:9

    Topics: Aged; Aged, 80 and over; Anemia; Chronic Disease; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Neurotransmitter Agents; Pilot Projects; Prospective Studies; Recombinant Proteins; Survival Rate; Syndrome; Time Factors; Treatment Outcome

2009
Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Blood Chemical Analysis; Bone Marrow; Bone Marrow Examination; Chi-Square Distribution; Chronic Disease; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron; Kidney Diseases; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Time Factors; Transferrin; Treatment Outcome; Young Adult

2010
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma.
    Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:3

    Topics: Animals; Comparative Genomic Hybridization; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gene Deletion; Gene Expression Profiling; Genes, p16; Glucaric Acid; Hematinics; Male; Mesoderm; Mesothelioma; Mucoproteins; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Peritoneal Neoplasms; Rats; Rats, Inbred F344; Rats, Wistar; Transcription Factors; Uromodulin

2010
Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
    The British journal of surgery, 2010, Volume: 97, Issue:2

    Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic

2010
Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
    The British journal of surgery, 2010, Volume: 97, Issue:2

    Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Randomized Controlled Trials as Topic

2010
[Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:10

    Topics: Adult; Anemia; Anti-Anxiety Agents; Anticoagulants; Cervix Uteri; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Dalteparin; Embolization, Therapeutic; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immobilization; Jehovah's Witnesses; Menorrhagia; Oxygen Inhalation Therapy; Parenteral Nutrition; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Thromboembolism; Treatment Refusal; Young Adult

2009
Iron replacement therapy: assessing today's options to prepare for bundling.
    Nephrology news & issues, 2010, Volume: 24, Issue:2

    Topics: Anemia, Iron-Deficiency; Chemistry, Pharmaceutical; Dextrans; Drug Costs; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Medicare; Reimbursement Mechanisms; Renal Dialysis; Risk Adjustment; Safety; Sucrose; Treatment Outcome; United States

2010
Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2010, Volume: 14, Issue:2

    Topics: Aged; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors

2010
Delayed adverse reactions to iron polymaltose and iron sucrose.
    Internal medicine journal, 2010, Volume: 40, Issue:2

    Topics: Dizziness; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Humans; Time Factors

2010
Eosinophilic fasciitis secondary to intravenous iron infusions.
    Dermatology online journal, 2010, May-15, Volume: 16, Issue:5

    Topics: Adult; Anemia, Iron-Deficiency; Eosinophilia; Fasciitis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous

2010
Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:2

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Blood Urea Nitrogen; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Chemokine CCL2; Disease Models, Animal; Endotoxins; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Gene Expression Regulation; Glucaric Acid; Gluconates; Glycerol; Heme Oxygenase-1; Humans; Injections, Intravenous; Kidney Tubules, Proximal; Lipocalin-2; Lipocalins; Membrane Proteins; Mice; Oncogene Proteins; Oxidative Stress; Proto-Oncogene Proteins; RNA, Messenger

2010
[Treatment with intravenous iron and ferritin level].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:3

    Topics: Anemia; Blood Proteins; Case-Control Studies; Clinical Protocols; Drug Monitoring; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Oxidation-Reduction; Prospective Studies; Renal Dialysis

2010
Response to iron sucrose in dialysis patients sensitive to iron dextran.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:4

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis

2010
Influence of intravenous iron therapy on novel markers of iron deficiency.
    The International journal of artificial organs, 2010, Volume: 33, Issue:5

    Topics: Anemia, Iron-Deficiency; Biomarkers; Cross-Sectional Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Reticulocytes; Time Factors; Transferrin; Treatment Outcome

2010
The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents.
    Artificial organs, 2011, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis

2011
In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:7

    Topics: Cell Survival; Dextrans; Ferric Compounds; Ferric Oxide, Saccharated; Free Radical Scavengers; Glucaric Acid; Hep G2 Cells; Humans; Iron; Oxidation-Reduction; Reactive Oxygen Species

2010
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.
    BMC nephrology, 2010, Aug-17, Volume: 11

    Topics: CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; GPI-Linked Proteins; Humans; Iron-Dextran Complex; Lymphocyte Subsets; Molecular Weight; Oxidative Stress; Reactive Oxygen Species; Receptors, IgG; Sucrose

2010
Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
    Anaesthesia and intensive care, 2010, Volume: 38, Issue:5

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Preoperative Care

2010
The therapeutic equivalence of complex drugs.
    Regulatory toxicology and pharmacology : RTP, 2011, Volume: 59, Issue:1

    Topics: Anticoagulants; Biological Products; Congresses as Topic; Consumer Product Safety; Drugs, Generic; Evidence-Based Medicine; Ferric Compounds; Ferric Oxide, Saccharated; Glatiramer Acetate; Glucaric Acid; Hematinics; Heparin, Low-Molecular-Weight; Humans; Immunosuppressive Agents; Legislation, Drug; Liposomes; Patents as Topic; Peptides; Proteins; Risk Assessment; Sucrose; Therapeutic Equivalency

2011
The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Care Costs; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Young Adult

2010
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
    The Korean journal of internal medicine, 2010, Volume: 25, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans

2010
Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran.
    Nephron. Clinical practice, 2011, Volume: 118, Issue:3

    Topics: Adult; Aged; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Humans; Iron; Male; Middle Aged; Oxidative Stress; Protein Carbonylation; Renal Dialysis

2011
Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis.
    Journal of renal care, 2011, Volume: 37, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Young Adult

2011
Should intravenous iron be upfront therapy for iron deficiency anemia?
    Pediatric blood & cancer, 2011, Volume: 56, Issue:4

    Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron-Dextran Complex; Molecular Weight

2011
Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.
    Pediatric blood & cancer, 2011, Volume: 56, Issue:4

    Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Infusions, Intravenous; Male

2011
Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
    Renal failure, 2011, Volume: 33, Issue:3

    Topics: Adult; Aged; Anemia; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis

2011
Physicochemical and toxicological characterization of a new generic iron sucrose preparation.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:2

    Topics: Algorithms; Animals; Chromatography, Gel; Chromatography, High Pressure Liquid; Creatinine; Drugs, Generic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Iron; Kinetics; Liver Function Tests; Microscopy, Atomic Force; Molecular Weight; Nephelometry and Turbidimetry; Particle Size; Polarography; Proteinuria; Rats; Rats, Sprague-Dawley; Reference Standards; Superoxide Dismutase

2011
Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients.
    American journal of nephrology, 2011, Volume: 33, Issue:5

    Topics: Aged; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Vitamin D

2011
Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2011, Volume: 15, Issue:3

    Topics: Adult; Aged; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies

2011
New rat models of iron sucrose-induced iron overload.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:7

    Topics: Animals; Antimicrobial Cationic Peptides; Biomarkers; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression; Glucaric Acid; Hepcidins; Humans; Inflammation; Iron; Iron Overload; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Serum; Time Factors

2011
Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:5

    Topics: Anaphylaxis; Drug Hypersensitivity; Europe; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron Compounds; Iron-Dextran Complex; North America; Odds Ratio; United States; United States Food and Drug Administration

2011
IBD: Intravenous iron in IBD--what's the best preparation?
    Nature reviews. Gastroenterology & hepatology, 2011, Jul-26, Volume: 8, Issue:9

    Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Maltose; Quality of Life; Treatment Outcome

2011
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
    British journal of anaesthesia, 2011, Volume: 107, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Costs and Cost Analysis; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Preoperative Care

2011
Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations.
    Bioanalysis, 2011, Volume: 3, Issue:16

    Topics: Anemia, Iron-Deficiency; Colorimetry; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Reproducibility of Results; Spectrophotometry; Transferrin

2011
Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:7

    Topics: Animals; Antioxidants; Blood Pressure; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Heart; Hematinics; Immunohistochemistry; Inflammation; Injections, Intravenous; Iron-Dextran Complex; Kidney; Lipid Peroxidation; Liver; Magnetite Nanoparticles; Male; Maltose; Molecular Weight; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley

2011
Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
    Renal failure, 2012, Volume: 34, Issue:1

    Topics: Adult; Aged; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis

2012
Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in rat.
    FEMS immunology and medical microbiology, 2012, Volume: 64, Issue:2

    Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cytokines; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Overload; Lipopolysaccharides; Lung; Male; Peroxidase; Pneumonia; Pseudomonas aeruginosa; Rats; Rats, Wistar; Weaning

2012
Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:10

    Topics: Animals; Biomarkers; Blood Pressure; Creatinine; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Immunohistochemistry; Inflammation; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney; Liver; Liver Function Tests; Male; Molecular Weight; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley

2011
[Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011, Oct-10, Volume: 100, Issue:10

    Topics: Aged; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Hypophosphatemia; Male; Osteomalacia

2011
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Current medical research and opinion, 2012, Volume: 28, Issue:2

    Topics: Adult; Anemia, Iron-Deficiency; Drugs, Generic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron, Dietary; Middle Aged; Therapeutic Equivalency; Young Adult

2012
Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.
    American journal of nephrology, 2012, Volume: 35, Issue:2

    Topics: Animals; Aorta, Thoracic; Cell Adhesion; Cell Survival; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Male; Monocytes; Rats; Rats, Sprague-Dawley; Vasodilation

2012
Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
    Inflammation & allergy drug targets, 2012, Volume: 11, Issue:1

    Topics: Anemia, Iron-Deficiency; Animals; Disease Models, Animal; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley

2012
Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
    JPMA. The Journal of the Pakistan Medical Association, 2011, Volume: 61, Issue:10

    Topics: Academic Medical Centers; Adult; Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Hematinics; Humans; Pakistan; Preoperative Care; Recombinant Proteins; Reticulocyte Count; Time Factors; Treatment Outcome

2011
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.
    American journal of nephrology, 2012, Volume: 36, Issue:1

    Topics: Adult; Anemia; Apoptosis; Carbohydrates; Escherichia coli; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Neutrophils; Phagocytosis; Staphylococcus aureus; Time Factors

2012
Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
    Journal of perinatal medicine, 2012, Apr-02, Volume: 40, Issue:4

    Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Transfusion; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Maltose; Puerperal Disorders; Retrospective Studies; Treatment Outcome

2012
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
    The American journal of cardiology, 2012, Oct-01, Volume: 110, Issue:7

    Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome

2012
Changing patterns of anemia management in US hemodialysis patients.
    The American journal of medicine, 2012, Volume: 125, Issue:9

    Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron Compounds; Kidney Failure, Chronic; Male; Middle Aged; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; United States

2012
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
    Journal of perinatal medicine, 2012, May-13, Volume: 40, Issue:5

    Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Young Adult

2012
Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies.
    Regulatory toxicology and pharmacology : RTP, 2012, Volume: 64, Issue:2

    Topics: Animals; Drug Approval; Drugs, Generic; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Metal Nanoparticles; Therapeutic Equivalency

2012
Comparative rates of adverse events with different formulations of intravenous iron.
    American journal of hematology, 2012, Volume: 87, Issue:11

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Multivariate Analysis; Retrospective Studies

2012
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:17

    Topics: Absorptiometry, Photon; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Osteomalacia; Phosphorus; Time Factors; Treatment Outcome; Withholding Treatment

2012
An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic.
    Journal of medical economics, 2013, Volume: 16, Issue:1

    Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Clinical Protocols; Costs and Cost Analysis; Decision Support Techniques; Efficiency, Organizational; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospitalization; Humans; Maltose; Patient Preference; Renal Insufficiency, Chronic; Transportation; United Kingdom

2013
eComment. The problem of anaemia correction in cardiac surgery patients.
    Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:6

    Topics: Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Sucrose

2012
[Preoperative intravenous iron as a strategy for blood saving in surgery for hip fracture].
    Medicina clinica, 2013, Nov-02, Volume: 141, Issue:9

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Case-Control Studies; Cross Infection; Drug Evaluation; Erythrocyte Transfusion; Erythropoiesis; Female; Femoral Neck Fractures; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Premedication; Preoperative Care; Retrospective Studies; Surgical Wound Infection

2013
Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
    Current medical research and opinion, 2013, Volume: 29, Issue:2

    Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Confidence Intervals; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Medical Audit; Middle Aged; Obstetric Surgical Procedures; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Republic of Korea; Retrospective Studies

2013
Uncommon adverse effect of a common medication.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Jan-22, Volume: 133, Issue:2

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Osteomalacia; Pelvic Pain; Remission Induction; Treatment Outcome

2013
Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia.
    Die Pharmazie, 2012, Volume: 67, Issue:12

    Topics: Aged; Aging; Anemia, Hypochromic; Asian People; Colloids; Contrast Media; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Sex Characteristics

2012
Adverse reaction to intravenous iron: hypersensitivity or secondary side effect?
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Jan-18, Volume: 33, Issue:1

    Topics: Adult; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Sucrose

2013
Optimizing preoperative haemoglobin with intravenous iron.
    British journal of anaesthesia, 2013, Volume: 110, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobinometry; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Recombinant Proteins; Young Adult

2013
A case study of an iron-deficient female Olympic 1500-m runner.
    International journal of sports physiology and performance, 2013, Volume: 8, Issue:6

    Topics: Adolescent; Anemia, Iron-Deficiency; Athletes; Athletic Performance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Lactic Acid; Oxygen Consumption; Running; Sucrose; Young Adult

2013
Iatrogenic osteomalacia: report of two cases.
    Journal of UOEH, 2013, Mar-01, Volume: 35, Issue:1

    Topics: Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gastrectomy; Glucaric Acid; Humans; Hypophosphatasia; Iatrogenic Disease; Male; Middle Aged; Osteomalacia; Postoperative Complications; Vitamin D Deficiency

2013
Managing severe anemia when the patient is a Jehovah's Witness.
    JAAPA : official journal of the American Academy of Physician Assistants, 2013, Volume: 26, Issue:4

    Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex

2013
Oxidative effect of several intravenous iron complexes in the rat.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2013, Volume: 26, Issue:3

    Topics: Administration, Intravenous; Animals; Dinitrobenzenes; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Maltose; Oxidative Stress; Rats; Tissue Distribution; Tyrosine

2013
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
    Pharmaceutical development and technology, 2014, Volume: 19, Issue:5

    Topics: Anemia, Iron-Deficiency; Chromatography, Gel; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Sucrose

2014
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10

    Topics: Anemia, Iron-Deficiency; Central Venous Catheters; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Infusions, Intravenous; Maltose; Neoplasms; Practice Patterns, Physicians'; Surveys and Questionnaires

2013
Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria.
    British journal of haematology, 2013, Volume: 163, Issue:2

    Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Protoporphyria, Erythropoietic; Sucrose; Treatment Outcome; Young Adult

2013
[Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration].
    Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2013, Volume: 107, Issue:4-5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Child; Child, Preschool; Cost Savings; Cross-Sectional Studies; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Iron Compounds; Male; Maltose; Middle Aged; National Health Programs; Off-Label Use; Retrospective Studies; Switzerland; Young Adult

2013
Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
    Sleep medicine, 2013, Volume: 14, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Age of Onset; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Male; Nocturnal Myoclonus Syndrome; Polysomnography; Restless Legs Syndrome; Retrospective Studies

2013
Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.
    Sleep medicine, 2013, Volume: 14, Issue:11

    Topics: Administration, Intravenous; Adult; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Pregnancy; Pregnancy Complications; Restless Legs Syndrome; Treatment Outcome

2013
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Transfusion; Feasibility Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome

2013
Use of intravenous iron sucrose for treatment of anaemia in pregnancy.
    The Indian journal of medical research, 2013, Volume: 138

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic

2013
Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy.
    The Indian journal of medical research, 2013, Volume: 138

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies

2013
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2014, Volume: 15, Issue:9

    Topics: Anemia, Iron-Deficiency; Budgets; Cost Savings; Drug Substitution; Female; Ferric Compounds; Ferric Oxide, Saccharated; Financing, Personal; Glucaric Acid; Humans; Maltose; National Health Programs; Switzerland

2014
Ferumoxytol: an intravenous iron, riskier than iron sucrose.
    Prescrire international, 2013, Volume: 22, Issue:141

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans

2013
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
    Pharmaceutical development and technology, 2015, Volume: 20, Issue:2

    Topics: Anemia, Iron-Deficiency; Biological Availability; Cell Culture Techniques; Dose-Response Relationship, Drug; Drug Liberation; Drug Stability; Drugs, Generic; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Injections, Intravenous; Macrophages; Spectrophotometry, Atomic; Sucrose

2015
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.
    International journal of hematology, 2014, Volume: 99, Issue:1

    Topics: Animals; Cell Line; Coculture Techniques; Cytokines; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hep G2 Cells; Hepcidins; Humans; Iron; Leukocytes, Mononuclear; Male; Monocytes; Rats; Spleen; Transferrin

2014
Hydroxyurea could be a good clinically relevant iron chelator.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Antisickling Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hydroxyurea; Iron Chelating Agents; Iron Overload; Liver; Male; Mice; Mice, Inbred BALB C; Myocardium; Time Factors

2013
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.
    International journal of pharmaceutics, 2014, Apr-10, Volume: 464, Issue:1-2

    Topics: Chemistry, Pharmaceutical; Colloids; Drug Stability; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Thermodynamics

2014
Identification of the sentinel node by ultrasonography in patients with breast cancer.
    Annals of surgical oncology, 2014, Volume: 21, Issue:6

    Topics: Adult; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Breast Neoplasms, Male; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Signal Processing, Computer-Assisted; Sucrose; Technetium; Ultrasonography; Young Adult

2014
Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:4

    Topics: Aged; Anemia, Iron-Deficiency; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Lasers, Solid-State; Male; Skin Diseases; Sucrose

2015
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2013, Volume: 67, Issue:5

    Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose

2013
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.
    Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:11

    Topics: Animals; Atherosclerosis; Cell Adhesion; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Intercellular Adhesion Molecule-1; Leukocytes; Lipid Peroxidation; Male; Mice, Inbred C57BL; Monocytes; NF-kappa B; Renal Insufficiency, Chronic; Superoxides; U937 Cells; Up-Regulation; Vascular Cell Adhesion Molecule-1

2014
Rapid iron desensitization after generalized urticaria and facial angioedema.
    Journal of investigational allergology & clinical immunology, 2014, Volume: 24, Issue:1

    Topics: Anemia, Iron-Deficiency; Angioedema; Desensitization, Immunologic; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Sucrose; Urticaria

2014
The uptake of particulate matter by endothelial cells.
    Proceedings of the Royal Society of London. Series B, Biological sciences, 1967, Jan-24, Volume: 166, Issue:1005

    Topics: Adrenal Glands; Animals; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Horses; Kupffer Cells; Liver; Mice; Myocardium; Rats; Spleen

1967
Cell viability and chondrogenic differentiation capability of human mesenchymal stem cells after iron labeling with iron sucrose.
    Stem cells and development, 2014, Nov-01, Volume: 23, Issue:21

    Topics: Adolescent; Adult; Aggrecans; Biomarkers; Cell Differentiation; Cell Survival; Cells, Cultured; Chondrocytes; Chondrogenesis; Collagen Type II; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Gene Expression; Glucaric Acid; Humans; Immunohistochemistry; Immunophenotyping; Iron; Mesenchymal Stem Cells; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; SOX9 Transcription Factor; Staining and Labeling; Sucrose; Time Factors; Transforming Growth Factor beta; Young Adult

2014
Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model.
    Drug research, 2015, Volume: 65, Issue:7

    Topics: Administration, Intravenous; Animals; Apoptosis; Caspase 3; Disaccharides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Kidney; Liver; Male; Maltose; Models, Animal; Myocardium; Rats; Tyrosine

2015
Anemia in the critically ill: do we need to live with it?*.
    Critical care medicine, 2014, Volume: 42, Issue:9

    Topics: Anemia; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male

2014
Assessment of the introduction of a blood management program in orthopaedic surgery.
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:8

    Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Banks; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Hospitals, University; Humans; Length of Stay; Male; Middle Aged; Operative Blood Salvage; Orthopedics; Postoperative Hemorrhage; Program Evaluation; Retrospective Studies; Spain; Tranexamic Acid

2015
Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2015, Volume: 28, Issue:1

    Topics: Ascorbic Acid; Cell Line; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Iron; Liver; Macrophages; Maltose

2015
Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2015, Volume: 28, Issue:2

    Topics: Animals; Apoptosis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Injections, Intradermal; Interleukin-6; Liver; Male; Rats, Sprague-Dawley; Reactive Nitrogen Species; Stress, Physiological; Sucrose; Tumor Necrosis Factor-alpha

2015
Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
    World journal of pediatrics : WJP, 2016, Volume: 12, Issue:1

    Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Male; Retrospective Studies

2016
Gastric Antral Vascular Ectasia (GAVE): an overlooked diagnosis.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:3

    Topics: Aged; Argon Plasma Coagulation; Endoscopy, Digestive System; Female; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Gastroscopy; Glucaric Acid; Humans; Treatment Outcome

2015
Electrophysiological and molecular mechanisms of protection by iron sucrose against phosphine-induced cardiotoxicity: a time course study.
    Toxicology mechanisms and methods, 2015, Volume: 25, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Death; Electrocardiography; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Diseases; Heart Rate; Hydroxyl Radical; Insecticides; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardium; Phosphines; Rats; Rats, Wistar

2015
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Animals; Cation Transport Proteins; Cell Line; Cell Survival; Disaccharides; Epithelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hepcidins; Humans; Iron; Iron-Dextran Complex; Kidney; Lipid Peroxidation; Macrophages, Peritoneal; Maltose; Oxidative Stress; Primary Cell Culture; Rats; Tumor Necrosis Factor-alpha

2015
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
    The American surgeon, 2015, Volume: 81, Issue:6

    Topics: Aged; Anemia; Aortic Aneurysm, Abdominal; Blood Loss, Surgical; Critical Illness; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Compounds; Jehovah's Witnesses; Male; Recombinant Proteins; Salvage Therapy

2015
Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.
    Cancer science, 2015, Volume: 106, Issue:10

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers, Tumor; Calbindin 2; Cell Cycle Proteins; Cell Line, Tumor; Chromosome Deletion; Deoxyguanosine; Down-Regulation; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron Overload; Lung Neoplasms; Male; Membrane Glycoproteins; Mesothelioma; Mesothelioma, Malignant; Neoplasms, Experimental; Nuclear Proteins; Rats; Rats, Wistar; RNA Splicing Factors; Thromboxane-A Synthase

2015
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015, Volume: 30, Issue:12

    Topics: Administration, Intravenous; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Stroke; United States

2015
Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 67, Issue:1

    Topics: Anemia, Iron-Deficiency; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Time Factors

2016
Transport of sucrose-modified nanoscale zero-valent iron in saturated porous media: role of media size, injection rate and input concentration.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2015, Volume: 72, Issue:9

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Groundwater; Iron; Kinetics; Metal Nanoparticles; Porosity; Silicon Dioxide; Sucrose; Suspensions

2015
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
    JAMA, 2015, Nov-17, Volume: 314, Issue:19

    Topics: Aged; Anaphylaxis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Gluconates; Humans; Incidence; Injections, Intravenous; Iron-Dextran Complex; Male; Medicare Part A; Retrospective Studies; Risk; United States

2015
Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
    Critical care medicine, 2016, Volume: 44, Issue:3

    Topics: Adult; Aged; Anemia; Antioxidants; Area Under Curve; C-Reactive Protein; Case-Control Studies; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Healthy Volunteers; Humans; Infusions, Intravenous; Interleukin-6; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress

2016
Potential of Alginate Encapsulated Ferric Saccharate Microemulsions to Ameliorate Iron Deficiency in Mice.
    Biological trace element research, 2016, Volume: 172, Issue:1

    Topics: Alginates; Anemia, Iron-Deficiency; Animals; Biological Availability; Caco-2 Cells; Cells, Cultured; Emulsions; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mice

2016
In Vitro Release Kinetics and Transferrin Saturation Study of Intravenous Iron Sucrose Entrapped in Poly(ethylene glycol)-Assisted Silica Xerogel.
    Applied biochemistry and biotechnology, 2016, Volume: 178, Issue:7

    Topics: Drug Carriers; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Ferric Oxide, Saccharated; Gels; Glucaric Acid; Humans; Kinetics; Polyethylene Glycols; Silicon Dioxide; Transferrin

2016
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Aged; Anemia; Darbepoetin alfa; Disease Management; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Renal Dialysis; Retrospective Studies

2016
Ferrous iron content of intravenous iron formulations.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:3

    Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Iron-Dextran Complex; Maltose

2016
Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
    International journal of pharmaceutics, 2016, May-30, Volume: 505, Issue:1-2

    Topics: Administration, Intravenous; Chemistry, Pharmaceutical; Drug Compounding; Dynamic Light Scattering; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Iron-Dextran Complex; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Temperature

2016
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
    Gut and liver, 2016, Jul-15, Volume: 10, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Parenteral; Male; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult

2016
Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
    International journal of cardiology, 2016, Jun-01, Volume: 212

    Topics: Anemia; Animals; Cardiotonic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fibrosis; Glucaric Acid; Inflammation; Infusions, Intravenous; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine; Ventricular Remodeling

2016
Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
    The American journal of cardiology, 2016, 06-15, Volume: 117, Issue:12

    Topics: Acute Disease; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome

2016
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
    Kidney international, 2016, Volume: 90, Issue:1

    Topics: Acute Kidney Injury; alpha 1-Antitrypsin; Alpha-Globulins; Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glycerol; Haptoglobins; Heme Oxygenase-1; Hemopexin; Hepcidins; Interleukin-10; Kidney; Male; Maleates; Metalloporphyrins; Mice; Protective Agents; Protoporphyrins; RNA, Messenger; Troponin C

2016
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:11

    Topics: Anemia, Iron-Deficiency; Case-Control Studies; Cell Differentiation; Dendritic Cells; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Macrophages; Maltose; MicroRNAs; Monocytes; Phagocytosis

2016
[Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Terapevticheskii arkhiv, 2016, Volume: 88, Issue:6

    Topics: Adult; Anemia; Biomarkers; Disease Progression; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glucuronidase; Hematinics; Hemoglobins; Humans; Iron; Klotho Proteins; Male; Middle Aged; Outcome Assessment, Health Care; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index

2016
Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease.
    Journal of pediatric gastroenterology and nutrition, 2016, Volume: 63, Issue:5

    Topics: Adolescent; Anemia, Iron-Deficiency; C-Reactive Protein; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Agents; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infliximab; Injections, Intravenous; Iron; Male; Prospective Studies

2016
Is there any role of intravenous iron for the treatment of anemia in cancer?
    BMC cancer, 2016, 08-20, Volume: 16, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome

2016
AMD-like retinopathy associated with intravenous iron.
    Experimental eye research, 2016, Volume: 151

    Topics: Animals; Apoferritins; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression Regulation; Glucaric Acid; Injections, Intravenous; Iron; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptors, Transferrin; Retinal Pigment Epithelium; RNA

2016
Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:1

    Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Male; Maltose; Portugal; Prospective Studies; Transferrin

2017
Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice.
    Vascular pharmacology, 2016, Volume: 87

    Topics: Administration, Oral; Animals; Baroreflex; Curcumin; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hypertension; Iron Chelating Agents; Iron Overload; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyridones

2016
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    American journal of nephrology, 2017, Volume: 45, Issue:1

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Complement Activation; Complement C1q; Complement C3d; Complement Membrane Attack Complex; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Mannose-Binding Lectin; Properdin; Renal Dialysis

2017
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3

    Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies

2017
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 69, Issue:6

    Topics: Administration, Intravenous; Aged; Anemia; Cardiovascular Diseases; Cause of Death; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Proportional Hazards Models; Renal Dialysis; Retrospective Studies

2017
Validation of a quantitative susceptibility mapping acquisition and reconstruction pipeline using a new iron sucrose based MR susceptibility phantom.
    Journal of neuroradiology = Journal de neuroradiologie, 2017, Volume: 44, Issue:4

    Topics: Equipment Design; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Phantoms, Imaging

2017
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation.
    Laboratory investigation; a journal of technical methods and pathology, 2017, Volume: 97, Issue:5

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblasts; Glucaric Acid; Hep G2 Cells; Humans; Iron; Kidney; Mice; Oxidative Stress; Up-Regulation; Ureteral Obstruction

2017
A Toddler With Severe Anemia, Pica, and Extremity Swelling.
    Journal of emergency nursing, 2017, Volume: 43, Issue:6

    Topics: Anemia; Blood Transfusion; Edema; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Foot; Glucaric Acid; Hematinics; Humans; Infant; Male; Oxygen Inhalation Therapy; Pica

2017
Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:5

    Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Iron; Male; Young Adult

2017
Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
    Translational research : the journal of laboratory and clinical medicine, 2017, Volume: 186

    Topics: Acute Kidney Injury; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression Regulation; Glucaric Acid; Male; Metalloporphyrins; Mice; NF-E2-Related Factor 2; Oxidants; Protein Binding; Protoporphyrins; Reperfusion Injury

2017
Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
    Transfusion, 2017, Volume: 57, Issue:10

    Topics: Anemia; Animals; Disease Models, Animal; Dogs; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron; Lung Injury; Mortality; Pneumonia, Bacterial; Pneumonia, Staphylococcal

2017
Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
    Redox biology, 2018, Volume: 14

    Topics: Ascorbic Acid; Catalase; Cell Survival; Colonic Neoplasms; Deferoxamine; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; HCT116 Cells; HT29 Cells; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Oxidative Stress

2018
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
    Medicine, 2017, Volume: 96, Issue:39

    Topics: Bone Density; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Hypocalcemia; Hypophosphatemia; Magnesium; Magnesium Deficiency; Middle Aged; Osteomalacia; Short Bowel Syndrome; Treatment Outcome; Withholding Treatment

2017
Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
    Expert opinion on drug delivery, 2017, Volume: 14, Issue:12

    Topics: Anemia, Iron-Deficiency; Budgets; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Retrospective Studies; United Kingdom

2017
Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Cell Line, Tumor; Cell Proliferation; Cytosine Deaminase; Exosomes; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; HeLa Cells; Humans; Hyperthermia, Induced; Magnetic Fields; Male; Mesenchymal Stem Cells; Nanoparticles; Pentosyltransferases; Prostatic Neoplasms; Recombinant Proteins

2017
Zinc deficiency anaemia in haemodialysis patients: Often overlooked but a treatable cause of anaemia.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:12

    Topics: Aged, 80 and over; Anemia; Biomarkers; Carnosine; Darbepoetin alfa; Deficiency Diseases; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Organometallic Compounds; Renal Dialysis; Treatment Outcome; Zinc; Zinc Compounds

2017
Iron sucrose: assessing the similarity between the originator drug and its intended copies.
    Annals of the New York Academy of Sciences, 2017, Volume: 1407, Issue:1

    Topics: Anemia, Iron-Deficiency; Biosimilar Pharmaceuticals; Chemical Phenomena; Chemistry, Pharmaceutical; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Particle Size; Technology, Pharmaceutical; Therapeutic Equivalency

2017
Influence of Carnicor, Venofer, and Sevelamer on the levels of genotoxic damage in end-stage renal disease patients.
    Environmental and molecular mutagenesis, 2018, Volume: 59, Issue:4

    Topics: Carnitine; Chelating Agents; Comet Assay; DNA Damage; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Neuroprotective Agents; Oxidative Stress; Sevelamer

2018
A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering.
    Journal of pharmaceutical and biomedical analysis, 2018, Apr-15, Volume: 152

    Topics: Anemia, Iron-Deficiency; Dynamic Light Scattering; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Light; Nanoparticles; Particle Size; Scattering, Radiation

2018
Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
    Regulatory toxicology and pharmacology : RTP, 2018, Volume: 94

    Topics: Amylopectin; Animals; Embryo, Nonmammalian; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Kidney; Liver; Maltose; Models, Animal; Myocardium; Nanoparticles; Therapeutic Equivalency; Turkey

2018
Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
    International journal of clinical pharmacy, 2018, Volume: 40, Issue:3

    Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inpatients; Length of Stay; Male; Maltose; Middle Aged; Retrospective Studies

2018
Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
    Annals of palliative medicine, 2021, Volume: 10, Issue:2

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hospitalization; Humans; Iron; Liver Diseases

2021
Iron Sucrose and Blood Pressure Patterns During Hemodialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023, Volume: 81, Issue:6

    Topics: Anemia, Iron-Deficiency; Blood Pressure; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Renal Dialysis

2023
Intravenous iron for critically ill children. Comparison of three dose regimens.
    Pediatric blood & cancer, 2024, Volume: 71, Issue:1

    Topics: Anemia; Anemia, Iron-Deficiency; Child; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron; Prospective Studies

2024